依田 成玄

Last Update: 2021/06/18 18:44:47

Print

Name(Kanji/Kana/Abecedarium Latinum)
依田 成玄/ヨダ アキノリ/Yoda, Akinori
Primary Affiliation(Org1/Job title)
Graduate Schools Medicine/Program-Specific Associate Professor
Academic Degree
Field(Japanese) Field(English) University(Japanese) University(English) Method
修士(理学) M.S. 東京大学 Tokyo University
博士(医学) Ph.D. 大阪大学 Osaka University
Personal Profile
(Japanese)
がんの研究、特に新規がん遺伝子の発がんにおける機能解析及びこの分子を標的とした新規抗がん剤の開発を行っている。
(English)
I am doing cancer research: functional analysis of novel oncogenes and development of novel cancer drugs targeting the oncogenes.
Language of Instruction
Language(japanese) Language(english) Code
英語 English eng
ORCID ID
https://orcid.org/0000-0002-7806-1909
researchmap URL
https://researchmap.jp/read0054674
Research Topics
(Japanese)
白血病の新規治療標的分子の研究
(English)
Novel therapeutic targets for leukemia
Overview of the research
(Japanese)
創薬ベンチャーと共同で、新規の抗がん剤及び新規のがん免疫療法薬の開発を行っている。このプロジェクトでは、患者検体(主に白血病・リンパ腫)やマウスin vivoモデル(ノックアウト・ノックイン、患者腫瘍組織移植PDXモデル、PD-1抗体治療モデル)のオミックス解析(DNA/RNAシークエンシング、プロテオミクス解析)を利用した創薬研究を行っている。
(English)
I am doing a research of drug development for cancer collaborating with biotech companies. In this project we employ the latest technologies including mouse in vivo models (knock-in/knock-out mice, patient-derived Xenograft (PDX) models and syngeneic mouse models for cancer immunotherapy) and OMICs analyses (DNA/RNA sequencing and proteomics analysis).
Fields of research (key words)
Key words(Japanese) Key words(English)
血液腫瘍学 Hematology/Oncology
がんと遺伝子 Oncogene
ゲノム解析 Genomic analysis
疾患モデル Disease model
Published Papers
Author Author(Japanese) Author(English) Title Title(Japanese) Title(English) Bibliography Bibliography(Japanese) Bibliography(English) Publication date Refereed paper Language Publishing type Disclose
Yotaro Ochi, Ayana Kon, Toyonori Sakata, Masahiro M Nakagawa, Naotaka Nakazawa, Masanori Kakuta, Keisuke Kataoka, Haruhiko Koseki, Manabu Nakayama, Daisuke Morishita, Tatsuaki Tsuruyama, Ryunosuke Saiki, Akinori Yoda, Rurika Okuda, Tetsuichi Yoshizato, Kenichi Yoshida, Yusuke Shiozawa, Yasuhito Nannya, Shinichi Kotani, Yasunori Kogure, Nobuyuki Kakiuchi, Tomomi Nishimura, Hideki Makishima, Luca Malcovati, Akihiko Yokoyama, Kengo Takeuchi, Eiji Sugihara, Taka-Aki Sato, Masashi Sanada, Akifumi Takaori-Kondo, Mario Cazzola, Mineko Kengaku, Satoru Miyano, Katsuhiko Shirahige, Hiroshi I Suzuki, Seishi Ogawa Yotaro Ochi, Ayana Kon, Toyonori Sakata, Masahiro M Nakagawa, Naotaka Nakazawa, Masanori Kakuta, Keisuke Kataoka, Haruhiko Koseki, Manabu Nakayama, Daisuke Morishita, Tatsuaki Tsuruyama, Ryunosuke Saiki, Akinori Yoda, Rurika Okuda, Tetsuichi Yoshizato, Kenichi Yoshida, Yusuke Shiozawa, Yasuhito Nannya, Shinichi Kotani, Yasunori Kogure, Nobuyuki Kakiuchi, Tomomi Nishimura, Hideki Makishima, Luca Malcovati, Akihiko Yokoyama, Kengo Takeuchi, Eiji Sugihara, Taka-Aki Sato, Masashi Sanada, Akifumi Takaori-Kondo, Mario Cazzola, Mineko Kengaku, Satoru Miyano, Katsuhiko Shirahige, Hiroshi I Suzuki, Seishi Ogawa Yotaro Ochi, Ayana Kon, Toyonori Sakata, Masahiro M Nakagawa, Naotaka Nakazawa, Masanori Kakuta, Keisuke Kataoka, Haruhiko Koseki, Manabu Nakayama, Daisuke Morishita, Tatsuaki Tsuruyama, Ryunosuke Saiki, Akinori Yoda, Rurika Okuda, Tetsuichi Yoshizato, Kenichi Yoshida, Yusuke Shiozawa, Yasuhito Nannya, Shinichi Kotani, Yasunori Kogure, Nobuyuki Kakiuchi, Tomomi Nishimura, Hideki Makishima, Luca Malcovati, Akihiko Yokoyama, Kengo Takeuchi, Eiji Sugihara, Taka-Aki Sato, Masashi Sanada, Akifumi Takaori-Kondo, Mario Cazzola, Mineko Kengaku, Satoru Miyano, Katsuhiko Shirahige, Hiroshi I Suzuki, Seishi Ogawa Combined Cohesin-RUNX1 Deficiency Synergistically Perturbs Chromatin Looping and Causes Myelodysplastic Syndromes. Combined Cohesin-RUNX1 Deficiency Synergistically Perturbs Chromatin Looping and Causes Myelodysplastic Syndromes. Combined Cohesin-RUNX1 Deficiency Synergistically Perturbs Chromatin Looping and Causes Myelodysplastic Syndromes. Cancer discovery, 10, 6, 836-853 Cancer discovery, 10, 6, 836-853 Cancer discovery, 10, 6, 836-853 2020/06 Refereed English Research paper(scientific journal) Disclose to all
Noriaki Yoshida, Kay Shigemori, Nicholas Donaldson, Christopher Trevisani, Nicolas A Cordero, Kristen E Stevenson, Xia Bu, Fumiko Arakawa, Mai Takeuchi, Koichi Ohshima, Akinori Yoda, Samuel Y Ng, David M Weinstock Noriaki Yoshida, Kay Shigemori, Nicholas Donaldson, Christopher Trevisani, Nicolas A Cordero, Kristen E Stevenson, Xia Bu, Fumiko Arakawa, Mai Takeuchi, Koichi Ohshima, Akinori Yoda, Samuel Y Ng, David M Weinstock Noriaki Yoshida, Kay Shigemori, Nicholas Donaldson, Christopher Trevisani, Nicolas A Cordero, Kristen E Stevenson, Xia Bu, Fumiko Arakawa, Mai Takeuchi, Koichi Ohshima, Akinori Yoda, Samuel Y Ng, David M Weinstock Genomic landscape of young ATLL patients identifies frequent targetable CD28 fusions. Genomic landscape of young ATLL patients identifies frequent targetable CD28 fusions. Genomic landscape of young ATLL patients identifies frequent targetable CD28 fusions. Blood, 135, 17, 1467-1471 Blood, 135, 17, 1467-1471 Blood, 135, 17, 1467-1471 2020/04/23 Refereed English Research paper(scientific journal) Disclose to all
Nobuyuki Kakiuchi, Kenichi Yoshida, Motoi Uchino, Takako Kihara, Kotaro Akaki, Yoshikage Inoue, Kenji Kawada, Satoshi Nagayama, Akira Yokoyama, Shuji Yamamoto, Minoru Matsuura, Takahiro Horimatsu, Tomonori Hirano, Norihiro Goto, Yasuhide Takeuchi, Yotaro Ochi, Yusuke Shiozawa, Yasunori Kogure, Yosaku Watatani, Yoichi Fujii, Soo Ki Kim, Ayana Kon, Keisuke Kataoka, Tetsuichi Yoshizato, Masahiro M Nakagawa, Akinori Yoda, Yasuhito Nanya, Hideki Makishima, Yuichi Shiraishi, Kenichi Chiba, Hiroko Tanaka, Masashi Sanada, Eiji Sugihara, Taka-Aki Sato, Takashi Maruyama, Hiroyuki Miyoshi, Makoto Mark Taketo, Jun Oishi, Ryosaku Inagaki, Yutaka Ueda, Shinya Okamoto, Hideaki Okajima, Yoshiharu Sakai, Takaki Sakurai, Hironori Haga, Seiichi Hirota, Hiroki Ikeuchi, Hiroshi Nakase, Hiroyuki Marusawa, Tsutomu Chiba, Osamu Takeuchi, Satoru Miyano, Hiroshi Seno, Seishi Ogawa Nobuyuki Kakiuchi, Kenichi Yoshida, Motoi Uchino, Takako Kihara, Kotaro Akaki, Yoshikage Inoue, Kenji Kawada, Satoshi Nagayama, Akira Yokoyama, Shuji Yamamoto, Minoru Matsuura, Takahiro Horimatsu, Tomonori Hirano, Norihiro Goto, Yasuhide Takeuchi, Yotaro Ochi, Yusuke Shiozawa, Yasunori Kogure, Yosaku Watatani, Yoichi Fujii, Soo Ki Kim, Ayana Kon, Keisuke Kataoka, Tetsuichi Yoshizato, Masahiro M Nakagawa, Akinori Yoda, Yasuhito Nanya, Hideki Makishima, Yuichi Shiraishi, Kenichi Chiba, Hiroko Tanaka, Masashi Sanada, Eiji Sugihara, Taka-Aki Sato, Takashi Maruyama, Hiroyuki Miyoshi, Makoto Mark Taketo, Jun Oishi, Ryosaku Inagaki, Yutaka Ueda, Shinya Okamoto, Hideaki Okajima, Yoshiharu Sakai, Takaki Sakurai, Hironori Haga, Seiichi Hirota, Hiroki Ikeuchi, Hiroshi Nakase, Hiroyuki Marusawa, Tsutomu Chiba, Osamu Takeuchi, Satoru Miyano, Hiroshi Seno, Seishi Ogawa Nobuyuki Kakiuchi, Kenichi Yoshida, Motoi Uchino, Takako Kihara, Kotaro Akaki, Yoshikage Inoue, Kenji Kawada, Satoshi Nagayama, Akira Yokoyama, Shuji Yamamoto, Minoru Matsuura, Takahiro Horimatsu, Tomonori Hirano, Norihiro Goto, Yasuhide Takeuchi, Yotaro Ochi, Yusuke Shiozawa, Yasunori Kogure, Yosaku Watatani, Yoichi Fujii, Soo Ki Kim, Ayana Kon, Keisuke Kataoka, Tetsuichi Yoshizato, Masahiro M Nakagawa, Akinori Yoda, Yasuhito Nanya, Hideki Makishima, Yuichi Shiraishi, Kenichi Chiba, Hiroko Tanaka, Masashi Sanada, Eiji Sugihara, Taka-Aki Sato, Takashi Maruyama, Hiroyuki Miyoshi, Makoto Mark Taketo, Jun Oishi, Ryosaku Inagaki, Yutaka Ueda, Shinya Okamoto, Hideaki Okajima, Yoshiharu Sakai, Takaki Sakurai, Hironori Haga, Seiichi Hirota, Hiroki Ikeuchi, Hiroshi Nakase, Hiroyuki Marusawa, Tsutomu Chiba, Osamu Takeuchi, Satoru Miyano, Hiroshi Seno, Seishi Ogawa Frequent mutations that converge on the NFKBIZ pathway in ulcerative colitis. Frequent mutations that converge on the NFKBIZ pathway in ulcerative colitis. Frequent mutations that converge on the NFKBIZ pathway in ulcerative colitis. Nature, 577, 7789, 260-265 Nature, 577, 7789, 260-265 Nature, 577, 7789, 260-265 2020/01 English Research paper(scientific journal) Disclose to all
Shinichi Kotani, Akinori Yoda, Ayana Kon, Keisuke Kataoka, Yotaro Ochi, Yusuke Shiozawa, Cassandra Hirsch, June Takeda, Hiroo Ueno, Tetsuichi Yoshizato, Kenichi Yoshida, Masahiro M Nakagawa, Yasuhito Nannya, Nobuyuki Kakiuchi, Takuji Yamauchi, Kosuke Aoki, Yuichi Shiraishi, Satoru Miyano, Takahiro Maeda, Jaroslaw P Maciejewski, Akifumi Takaori-Kondo, Seishi Ogawa, Hideki Makishima Shinichi Kotani, Akinori Yoda, Ayana Kon, Keisuke Kataoka, Yotaro Ochi, Yusuke Shiozawa, Cassandra Hirsch, June Takeda, Hiroo Ueno, Tetsuichi Yoshizato, Kenichi Yoshida, Masahiro M Nakagawa, Yasuhito Nannya, Nobuyuki Kakiuchi, Takuji Yamauchi, Kosuke Aoki, Yuichi Shiraishi, Satoru Miyano, Takahiro Maeda, Jaroslaw P Maciejewski, Akifumi Takaori-Kondo, Seishi Ogawa, Hideki Makishima Shinichi Kotani, Akinori Yoda, Ayana Kon, Keisuke Kataoka, Yotaro Ochi, Yusuke Shiozawa, Cassandra Hirsch, June Takeda, Hiroo Ueno, Tetsuichi Yoshizato, Kenichi Yoshida, Masahiro M Nakagawa, Yasuhito Nannya, Nobuyuki Kakiuchi, Takuji Yamauchi, Kosuke Aoki, Yuichi Shiraishi, Satoru Miyano, Takahiro Maeda, Jaroslaw P Maciejewski, Akifumi Takaori-Kondo, Seishi Ogawa, Hideki Makishima Molecular pathogenesis of disease progression in MLL-rearranged AML. Molecular pathogenesis of disease progression in MLL-rearranged AML. Molecular pathogenesis of disease progression in MLL-rearranged AML. Leukemia, 33, 3, 612-624 Leukemia, 33, 3, 612-624 Leukemia, 33, 3, 612-624 2019/03 Refereed English Research paper(scientific journal) Disclose to all
Nannya, Yasuhito, Yoshida, Kenichi, Zhao, Lanying, Takeda, June, Ueno, Hiroo, Yoshizato, Tetsuichi, Yoda, Akinori, Nakagawa, Masahiro, Makishima, Hideki, Tanaka, Hiroko, Hiramoto, Nobuhiro, Muto, Hideharu, Fuji, Shigeo, Polprasert, Chantana, Damm, Frederik, Usuki, Kensuke, Taguchi, Masataka, Chiba, Shigeru, Miyawaki, Shuichi, Shih, Lee-Yung, Tsurumi, Hisashi, Kasahara, Senji, Malcovati, Luca, Ishikawa, Takayuki, Jansen, Joop H, Miyazaki, Yasushi, Miyano, Satoru, Cazzola, Mario, Ogawa, Seishi Nannya, Yasuhito, Yoshida, Kenichi, Zhao, Lanying, Takeda, June, Ueno, Hiroo, Yoshizato, Tetsuichi, Yoda, Akinori, Nakagawa, Masahiro, Makishima, Hideki, Tanaka, Hiroko, Hiramoto, Nobuhiro, Muto, Hideharu, Fuji, Shigeo, Polprasert, Chantana, Damm, Frederik, Usuki, Kensuke, Taguchi, Masataka, Chiba, Shigeru, Miyawaki, Shuichi, Shih, Lee-Yung, Tsurumi, Hisashi, Kasahara, Senji, Malcovati, Luca, Ishikawa, Takayuki, Jansen, Joop H, Miyazaki, Yasushi, Miyano, Satoru, Cazzola, Mario, Ogawa, Seishi Nannya, Yasuhito, Yoshida, Kenichi, Zhao, Lanying, Takeda, June, Ueno, Hiroo, Yoshizato, Tetsuichi, Yoda, Akinori, Nakagawa, Masahiro, Makishima, Hideki, Tanaka, Hiroko, Hiramoto, Nobuhiro, Muto, Hideharu, Fuji, Shigeo, Polprasert, Chantana, Damm, Frederik, Usuki, Kensuke, Taguchi, Masataka, Chiba, Shigeru, Miyawaki, Shuichi, Shih, Lee-Yung, Tsurumi, Hisashi, Kasahara, Senji, Malcovati, Luca, Ishikawa, Takayuki, Jansen, Joop H, Miyazaki, Yasushi, Miyano, Satoru, Cazzola, Mario, Ogawa, Seishi Genome-Wide Analysis of Non-Coding Alterations in Pan-Myeloid Cancers Using Whole Genome Sequencing Genome-Wide Analysis of Non-Coding Alterations in Pan-Myeloid Cancers Using Whole Genome Sequencing Genome-Wide Analysis of Non-Coding Alterations in Pan-Myeloid Cancers Using Whole Genome Sequencing BLOOD, 132, 1 BLOOD, 132, 1 BLOOD, 132, 1 2018/11 English Research paper(international conference proceedings) Disclose to all
Cailin E Joyce, Adrienne G Yanez, Akihiro Mori, Akinori Yoda, Johanna S Carroll, Carl D Novina Cailin E Joyce, Adrienne G Yanez, Akihiro Mori, Akinori Yoda, Johanna S Carroll, Carl D Novina Cailin E Joyce, Adrienne G Yanez, Akihiro Mori, Akinori Yoda, Johanna S Carroll, Carl D Novina Differential Regulation of the Melanoma Proteome by eIF4A1 and eIF4E. Differential Regulation of the Melanoma Proteome by eIF4A1 and eIF4E. Differential Regulation of the Melanoma Proteome by eIF4A1 and eIF4E. Cancer research, 77, 3, 613-622 Cancer research, 77, 3, 613-622 Cancer research, 77, 3, 613-622 2017/02/01 Refereed English Research paper(scientific journal) Disclose to all
Andrew Dunford, David M Weinstock, Virginia Savova, Steven E Schumacher, John P Cleary, Akinori Yoda, Timothy J Sullivan, Julian M Hess, Alexander A Gimelbrant, Rameen Beroukhim, Michael S Lawrence, Gad Getz, Andrew A Lane Andrew Dunford, David M Weinstock, Virginia Savova, Steven E Schumacher, John P Cleary, Akinori Yoda, Timothy J Sullivan, Julian M Hess, Alexander A Gimelbrant, Rameen Beroukhim, Michael S Lawrence, Gad Getz, Andrew A Lane Andrew Dunford, David M Weinstock, Virginia Savova, Steven E Schumacher, John P Cleary, Akinori Yoda, Timothy J Sullivan, Julian M Hess, Alexander A Gimelbrant, Rameen Beroukhim, Michael S Lawrence, Gad Getz, Andrew A Lane Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias. Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias. Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias. Nature genetics, 49, 1, 10-16 Nature genetics, 49, 1, 10-16 Nature genetics, 49, 1, 10-16 2017/01 Refereed English Research paper(scientific journal) Disclose to all
Jennifer M Grants, Lisa T L Ying, Akinori Yoda, Charlotte C You, Hideyuki Okano, Hitoshi Sawa, Stefan Taubert Jennifer M Grants, Lisa T L Ying, Akinori Yoda, Charlotte C You, Hideyuki Okano, Hitoshi Sawa, Stefan Taubert Jennifer M Grants, Lisa T L Ying, Akinori Yoda, Charlotte C You, Hideyuki Okano, Hitoshi Sawa, Stefan Taubert The Mediator Kinase Module Restrains Epidermal Growth Factor Receptor Signaling and Represses Vulval Cell Fate Specification in Caenorhabditis elegans. The Mediator Kinase Module Restrains Epidermal Growth Factor Receptor Signaling and Represses Vulval Cell Fate Specification in Caenorhabditis elegans. The Mediator Kinase Module Restrains Epidermal Growth Factor Receptor Signaling and Represses Vulval Cell Fate Specification in Caenorhabditis elegans. Genetics, 202, 2, 583-99 Genetics, 202, 2, 583-99 Genetics, 202, 2, 583-99 2016/02 Refereed English Research paper(scientific journal) Disclose to all
Shuo-Chieh Wu, Loretta S Li, Nadja Kopp, Joan Montero, Bjoern Chapuy, Akinori Yoda, Amanda L Christie, Huiyun Liu, Alexandra Christodoulou, Diederik van Bodegom, Jordy van der Zwet, Jacob V Layer, Trevor Tivey, Andrew A Lane, Jeremy A Ryan, Samuel Y Ng, Daniel J DeAngelo, Richard M Stone, David Steensma, Martha Wadleigh, Marian Harris, Emeline Mandon, Nicolas Ebel, Rita Andraos, Vincent Romanet, Arno Dölemeyer, Dario Sterker, Michael Zender, Scott J Rodig, Masato Murakami, Francesco Hofmann, Frank Kuo, Michael J Eck, Lewis B Silverman, Stephen E Sallan, Anthony Letai, Fabienne Baffert, Eric Vangrevelinghe, Thomas Radimerski, Christoph Gaul, David M Weinstock Shuo-Chieh Wu, Loretta S Li, Nadja Kopp, Joan Montero, Bjoern Chapuy, Akinori Yoda, Amanda L Christie, Huiyun Liu, Alexandra Christodoulou, Diederik van Bodegom, Jordy van der Zwet, Jacob V Layer, Trevor Tivey, Andrew A Lane, Jeremy A Ryan, Samuel Y Ng, Daniel J DeAngelo, Richard M Stone, David Steensma, Martha Wadleigh, Marian Harris, Emeline Mandon, Nicolas Ebel, Rita Andraos, Vincent Romanet, Arno Dölemeyer, Dario Sterker, Michael Zender, Scott J Rodig, Masato Murakami, Francesco Hofmann, Frank Kuo, Michael J Eck, Lewis B Silverman, Stephen E Sallan, Anthony Letai, Fabienne Baffert, Eric Vangrevelinghe, Thomas Radimerski, Christoph Gaul, David M Weinstock Shuo-Chieh Wu, Loretta S Li, Nadja Kopp, Joan Montero, Bjoern Chapuy, Akinori Yoda, Amanda L Christie, Huiyun Liu, Alexandra Christodoulou, Diederik van Bodegom, Jordy van der Zwet, Jacob V Layer, Trevor Tivey, Andrew A Lane, Jeremy A Ryan, Samuel Y Ng, Daniel J DeAngelo, Richard M Stone, David Steensma, Martha Wadleigh, Marian Harris, Emeline Mandon, Nicolas Ebel, Rita Andraos, Vincent Romanet, Arno Dölemeyer, Dario Sterker, Michael Zender, Scott J Rodig, Masato Murakami, Francesco Hofmann, Frank Kuo, Michael J Eck, Lewis B Silverman, Stephen E Sallan, Anthony Letai, Fabienne Baffert, Eric Vangrevelinghe, Thomas Radimerski, Christoph Gaul, David M Weinstock Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia. Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia. Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia. Cancer cell, 28, 1, 29-41 Cancer cell, 28, 1, 29-41 Cancer cell, 28, 1, 29-41 2015/07/13 Refereed English Research paper(scientific journal) Disclose to all
Marc R Mansour, Casie Reed, Amy R Eisenberg, Jen-Chieh Tseng, Jean-Claude Twizere, Sarah Daakour, Akinori Yoda, Scott J Rodig, Noa Tal, Chen Shochat, Alla Berezovskaya, Daniel J DeAngelo, Stephen E Sallan, David M Weinstock, Shai Izraeli, Andrew L Kung, Alex Kentsis, A Thomas Look Marc R Mansour, Casie Reed, Amy R Eisenberg, Jen-Chieh Tseng, Jean-Claude Twizere, Sarah Daakour, Akinori Yoda, Scott J Rodig, Noa Tal, Chen Shochat, Alla Berezovskaya, Daniel J DeAngelo, Stephen E Sallan, David M Weinstock, Shai Izraeli, Andrew L Kung, Alex Kentsis, A Thomas Look Marc R Mansour, Casie Reed, Amy R Eisenberg, Jen-Chieh Tseng, Jean-Claude Twizere, Sarah Daakour, Akinori Yoda, Scott J Rodig, Noa Tal, Chen Shochat, Alla Berezovskaya, Daniel J DeAngelo, Stephen E Sallan, David M Weinstock, Shai Izraeli, Andrew L Kung, Alex Kentsis, A Thomas Look Targeting oncogenic interleukin-7 receptor signalling with N-acetylcysteine in T cell acute lymphoblastic leukaemia. Targeting oncogenic interleukin-7 receptor signalling with N-acetylcysteine in T cell acute lymphoblastic leukaemia. Targeting oncogenic interleukin-7 receptor signalling with N-acetylcysteine in T cell acute lymphoblastic leukaemia. British journal of haematology, 168, 2, 230-8 British journal of haematology, 168, 2, 230-8 British journal of haematology, 168, 2, 230-8 2015/01 Refereed English Research paper(scientific journal) Disclose to all
Akinori Yoda, Guillaume Adelmant, Jerome Tamburini, Bjoern Chapuy, Nobuaki Shindoh, Yuka Yoda, Oliver Weigert, Nadja Kopp, Shuo-Chieh Wu, Sunhee S Kim, Huiyun Liu, Trevor Tivey, Amanda L Christie, Kutlu G Elpek, Joseph Card, Kira Gritsman, Jason Gotlib, Michael W Deininger, Hideki Makishima, Shannon J Turley, Nathalie Javidi-Sharifi, Jaroslaw P Maciejewski, Siddhartha Jaiswal, Benjamin L Ebert, Scott J Rodig, Jeffrey W Tyner, Jarrod A Marto, David M Weinstock, Andrew A Lane Yoda A, Adelmant G, Tamburini J, Chapuy B, Shindoh N, Yoda Y, Weigert O, Kopp N, Wu SC, Kim SS, Liu H, Tivey T, Christie AL, Elpek KG, Card J, Gritsman K, Gotlib J, Deininger MW, Makishima H, Turley SJ, Javidi-Sharifi N, Maciejewski JP, Jaiswal S, Ebert BL, Rodig SJ, Tyner JW, Marto JA, Weinstock DM, Lane AA Akinori Yoda, Guillaume Adelmant, Jerome Tamburini, Bjoern Chapuy, Nobuaki Shindoh, Yuka Yoda, Oliver Weigert, Nadja Kopp, Shuo-Chieh Wu, Sunhee S Kim, Huiyun Liu, Trevor Tivey, Amanda L Christie, Kutlu G Elpek, Joseph Card, Kira Gritsman, Jason Gotlib, Michael W Deininger, Hideki Makishima, Shannon J Turley, Nathalie Javidi-Sharifi, Jaroslaw P Maciejewski, Siddhartha Jaiswal, Benjamin L Ebert, Scott J Rodig, Jeffrey W Tyner, Jarrod A Marto, David M Weinstock, Andrew A Lane Mutations in G protein β subunits promote transformation and kinase inhibitor resistance. Mutations in G protein β subunits promote transformation and kinase inhibitor resistance. Mutations in G protein β subunits promote transformation and kinase inhibitor resistance. Nature medicine, 21, 1, 71-5 Nature medicine, 21, 1, 71-5 Nature medicine, 21, 1, 71-5 2015/01 Refereed English Research paper(scientific journal) Disclose to all
Andrew A Lane, Bjoern Chapuy, Charles Y Lin, Trevor Tivey, Hubo Li, Elizabeth C Townsend, Diederik van Bodegom, Tovah A Day, Shuo-Chieh Wu, Huiyun Liu, Akinori Yoda, Gabriela Alexe, Anna C Schinzel, Timothy J Sullivan, Sébastien Malinge, Jordan E Taylor, Kimberly Stegmaier, Jacob D Jaffe, Michael Bustin, Geertruy te Kronnie, Shai Izraeli, Marian H Harris, Kristen E Stevenson, Donna Neuberg, Lewis B Silverman, Stephen E Sallan, James E Bradner, William C Hahn, John D Crispino, David Pellman, David M Weinstock Andrew A Lane, Bjoern Chapuy, Charles Y Lin, Trevor Tivey, Hubo Li, Elizabeth C Townsend, Diederik van Bodegom, Tovah A Day, Shuo-Chieh Wu, Huiyun Liu, Akinori Yoda, Gabriela Alexe, Anna C Schinzel, Timothy J Sullivan, Sébastien Malinge, Jordan E Taylor, Kimberly Stegmaier, Jacob D Jaffe, Michael Bustin, Geertruy te Kronnie, Shai Izraeli, Marian H Harris, Kristen E Stevenson, Donna Neuberg, Lewis B Silverman, Stephen E Sallan, James E Bradner, William C Hahn, John D Crispino, David Pellman, David M Weinstock Andrew A Lane, Bjoern Chapuy, Charles Y Lin, Trevor Tivey, Hubo Li, Elizabeth C Townsend, Diederik van Bodegom, Tovah A Day, Shuo-Chieh Wu, Huiyun Liu, Akinori Yoda, Gabriela Alexe, Anna C Schinzel, Timothy J Sullivan, Sébastien Malinge, Jordan E Taylor, Kimberly Stegmaier, Jacob D Jaffe, Michael Bustin, Geertruy te Kronnie, Shai Izraeli, Marian H Harris, Kristen E Stevenson, Donna Neuberg, Lewis B Silverman, Stephen E Sallan, James E Bradner, William C Hahn, John D Crispino, David Pellman, David M Weinstock Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylation. Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylation. Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylation. Nature genetics, 46, 6, 618-23 Nature genetics, 46, 6, 618-23 Nature genetics, 46, 6, 618-23 2014/06 Refereed English Research paper(scientific journal) Disclose to all
Jun Zhong, Jyoti Sharma, Rajesh Raju, Shyam Mohan Palapetta, T S Keshava Prasad, Tai-Chung Huang, Akinori Yoda, Jeffrey W Tyner, Diederik van Bodegom, David M Weinstock, Steven F Ziegler, Akhilesh Pandey Jun Zhong, Jyoti Sharma, Rajesh Raju, Shyam Mohan Palapetta, T S Keshava Prasad, Tai-Chung Huang, Akinori Yoda, Jeffrey W Tyner, Diederik van Bodegom, David M Weinstock, Steven F Ziegler, Akhilesh Pandey Jun Zhong, Jyoti Sharma, Rajesh Raju, Shyam Mohan Palapetta, T S Keshava Prasad, Tai-Chung Huang, Akinori Yoda, Jeffrey W Tyner, Diederik van Bodegom, David M Weinstock, Steven F Ziegler, Akhilesh Pandey TSLP signaling pathway map: a platform for analysis of TSLP-mediated signaling. TSLP signaling pathway map: a platform for analysis of TSLP-mediated signaling. TSLP signaling pathway map: a platform for analysis of TSLP-mediated signaling. Database : the journal of biological databases and curation, 2014, bau007 Database : the journal of biological databases and curation, 2014, bau007 Database : the journal of biological databases and curation, 2014, bau007 2014 Refereed English Research paper(scientific journal) Disclose to all
Diederik van Bodegom, Jun Zhong, Nadja Kopp, Chaitali Dutta, Min-Sik Kim, Liat Bird, Oliver Weigert, Jeffrey Tyner, Akhilesh Pandey, Akinori Yoda, David M Weinstock Diederik van Bodegom, Jun Zhong, Nadja Kopp, Chaitali Dutta, Min-Sik Kim, Liat Bird, Oliver Weigert, Jeffrey Tyner, Akhilesh Pandey, Akinori Yoda, David M Weinstock Diederik van Bodegom, Jun Zhong, Nadja Kopp, Chaitali Dutta, Min-Sik Kim, Liat Bird, Oliver Weigert, Jeffrey Tyner, Akhilesh Pandey, Akinori Yoda, David M Weinstock Differences in signaling through the B-cell leukemia oncoprotein CRLF2 in response to TSLP and through mutant JAK2. Differences in signaling through the B-cell leukemia oncoprotein CRLF2 in response to TSLP and through mutant JAK2. Differences in signaling through the B-cell leukemia oncoprotein CRLF2 in response to TSLP and through mutant JAK2. Blood, 120, 14, 2853-63 Blood, 120, 14, 2853-63 Blood, 120, 14, 2853-63 2012/10/04 Refereed English Research paper(scientific journal) Disclose to all
Chaitali Dutta, Tovah Day, Nadja Kopp, Diederik van Bodegom, Matthew S Davids, Jeremy Ryan, Liat Bird, Naveen Kommajosyula, Oliver Weigert, Akinori Yoda, Hua Fung, Jennifer R Brown, Geoffrey I Shapiro, Anthony Letai, David M Weinstock Chaitali Dutta, Tovah Day, Nadja Kopp, Diederik van Bodegom, Matthew S Davids, Jeremy Ryan, Liat Bird, Naveen Kommajosyula, Oliver Weigert, Akinori Yoda, Hua Fung, Jennifer R Brown, Geoffrey I Shapiro, Anthony Letai, David M Weinstock Chaitali Dutta, Tovah Day, Nadja Kopp, Diederik van Bodegom, Matthew S Davids, Jeremy Ryan, Liat Bird, Naveen Kommajosyula, Oliver Weigert, Akinori Yoda, Hua Fung, Jennifer R Brown, Geoffrey I Shapiro, Anthony Letai, David M Weinstock BCL2 suppresses PARP1 function and nonapoptotic cell death. BCL2 suppresses PARP1 function and nonapoptotic cell death. BCL2 suppresses PARP1 function and nonapoptotic cell death. Cancer research, 72, 16, 4193-203 Cancer research, 72, 16, 4193-203 Cancer research, 72, 16, 4193-203 2012/08/15 Refereed English Research paper(scientific journal) Disclose to all
Jun Zhong, Min-Sik Kim, Raghothama Chaerkady, Xinyan Wu, Tai-Chung Huang, Derese Getnet, Christopher J Mitchell, Shyam M Palapetta, Jyoti Sharma, Robert N O'Meally, Robert N Cole, Akinori Yoda, Albrecht Moritz, Marc M Loriaux, John Rush, David M Weinstock, Jeffrey W Tyner, Akhilesh Pandey Jun Zhong, Min-Sik Kim, Raghothama Chaerkady, Xinyan Wu, Tai-Chung Huang, Derese Getnet, Christopher J Mitchell, Shyam M Palapetta, Jyoti Sharma, Robert N O'Meally, Robert N Cole, Akinori Yoda, Albrecht Moritz, Marc M Loriaux, John Rush, David M Weinstock, Jeffrey W Tyner, Akhilesh Pandey Jun Zhong, Min-Sik Kim, Raghothama Chaerkady, Xinyan Wu, Tai-Chung Huang, Derese Getnet, Christopher J Mitchell, Shyam M Palapetta, Jyoti Sharma, Robert N O'Meally, Robert N Cole, Akinori Yoda, Albrecht Moritz, Marc M Loriaux, John Rush, David M Weinstock, Jeffrey W Tyner, Akhilesh Pandey TSLP signaling network revealed by SILAC-based phosphoproteomics. TSLP signaling network revealed by SILAC-based phosphoproteomics. TSLP signaling network revealed by SILAC-based phosphoproteomics. Molecular & cellular proteomics : MCP, 11, 6, M112.017764 Molecular & cellular proteomics : MCP, 11, 6, M112.017764 Molecular & cellular proteomics : MCP, 11, 6, M112.017764 2012/06 Refereed English Research paper(scientific journal) Disclose to all
Oliver Weigert, Andrew A Lane, Liat Bird, Nadja Kopp, Bjoern Chapuy, Diederik van Bodegom, Angela V Toms, Sachie Marubayashi, Amanda L Christie, Michael McKeown, Ronald M Paranal, James E Bradner, Akinori Yoda, Christoph Gaul, Eric Vangrevelinghe, Vincent Romanet, Masato Murakami, Ralph Tiedt, Nicolas Ebel, Emeline Evrot, Alain De Pover, Catherine H Régnier, Dirk Erdmann, Francesco Hofmann, Michael J Eck, Stephen E Sallan, Ross L Levine, Andrew L Kung, Fabienne Baffert, Thomas Radimerski, David M Weinstock Oliver Weigert, Andrew A Lane, Liat Bird, Nadja Kopp, Bjoern Chapuy, Diederik van Bodegom, Angela V Toms, Sachie Marubayashi, Amanda L Christie, Michael McKeown, Ronald M Paranal, James E Bradner, Akinori Yoda, Christoph Gaul, Eric Vangrevelinghe, Vincent Romanet, Masato Murakami, Ralph Tiedt, Nicolas Ebel, Emeline Evrot, Alain De Pover, Catherine H Régnier, Dirk Erdmann, Francesco Hofmann, Michael J Eck, Stephen E Sallan, Ross L Levine, Andrew L Kung, Fabienne Baffert, Thomas Radimerski, David M Weinstock Oliver Weigert, Andrew A Lane, Liat Bird, Nadja Kopp, Bjoern Chapuy, Diederik van Bodegom, Angela V Toms, Sachie Marubayashi, Amanda L Christie, Michael McKeown, Ronald M Paranal, James E Bradner, Akinori Yoda, Christoph Gaul, Eric Vangrevelinghe, Vincent Romanet, Masato Murakami, Ralph Tiedt, Nicolas Ebel, Emeline Evrot, Alain De Pover, Catherine H Régnier, Dirk Erdmann, Francesco Hofmann, Michael J Eck, Stephen E Sallan, Ross L Levine, Andrew L Kung, Fabienne Baffert, Thomas Radimerski, David M Weinstock Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition. Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition. Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition. The Journal of experimental medicine, 209, 2, 259-73 The Journal of experimental medicine, 209, 2, 259-73 The Journal of experimental medicine, 209, 2, 259-73 2012/02/13 Refereed English Research paper(scientific journal) Disclose to all
Oliver Weigert, Nadja Kopp, Andrew A Lane, Akinori Yoda, Suzanne E Dahlberg, Donna Neuberg, Anita Y Bahar, Bjoern Chapuy, Jeffery L Kutok, Janina A Longtine, Frank C Kuo, Terry Haley, Maura Salois, Timothy J Sullivan, David C Fisher, Edward A Fox, Scott J Rodig, Joseph H Antin, David M Weinstock Oliver Weigert, Nadja Kopp, Andrew A Lane, Akinori Yoda, Suzanne E Dahlberg, Donna Neuberg, Anita Y Bahar, Bjoern Chapuy, Jeffery L Kutok, Janina A Longtine, Frank C Kuo, Terry Haley, Maura Salois, Timothy J Sullivan, David C Fisher, Edward A Fox, Scott J Rodig, Joseph H Antin, David M Weinstock Oliver Weigert, Nadja Kopp, Andrew A Lane, Akinori Yoda, Suzanne E Dahlberg, Donna Neuberg, Anita Y Bahar, Bjoern Chapuy, Jeffery L Kutok, Janina A Longtine, Frank C Kuo, Terry Haley, Maura Salois, Timothy J Sullivan, David C Fisher, Edward A Fox, Scott J Rodig, Joseph H Antin, David M Weinstock Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantation. Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantation. Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantation. Cancer discovery, 2, 1, 47-55 Cancer discovery, 2, 1, 47-55 Cancer discovery, 2, 1, 47-55 2012/01 Refereed English Research paper(scientific journal) Disclose to all
Nobuaki Shindoh, Akinori Yoda, Yuka Yoda, Timothy J Sullivan, Oliver Weigert, Andrew A Lane, Nadja Kopp, Liat Bird, Scott J Rodig, Edward A Fox, David M Weinstock Nobuaki Shindoh, Akinori Yoda, Yuka Yoda, Timothy J Sullivan, Oliver Weigert, Andrew A Lane, Nadja Kopp, Liat Bird, Scott J Rodig, Edward A Fox, David M Weinstock Nobuaki Shindoh, Akinori Yoda, Yuka Yoda, Timothy J Sullivan, Oliver Weigert, Andrew A Lane, Nadja Kopp, Liat Bird, Scott J Rodig, Edward A Fox, David M Weinstock Next-generation cDNA screening for oncogene and resistance phenotypes. Next-generation cDNA screening for oncogene and resistance phenotypes. Next-generation cDNA screening for oncogene and resistance phenotypes. PloS one, 7, 11, e49201 PloS one, 7, 11, e49201 PloS one, 7, 11, e49201 2012 Refereed English Research paper(scientific journal) Disclose to all
Albert G Tsai, Akinori Yoda, David M Weinstock, Michael R Lieber Albert G Tsai, Akinori Yoda, David M Weinstock, Michael R Lieber Albert G Tsai, Akinori Yoda, David M Weinstock, Michael R Lieber t(X;14)(p22;q32)/t(Y;14)(p11;q32) CRLF2-IGH translocations from human B-lineage ALLs involve CpG-type breaks at CRLF2, but CRLF2/P2RY8 intrachromosomal deletions do not. t(X;14)(p22;q32)/t(Y;14)(p11;q32) CRLF2-IGH translocations from human B-lineage ALLs involve CpG-type breaks at CRLF2, but CRLF2/P2RY8 intrachromosomal deletions do not. t(X;14)(p22;q32)/t(Y;14)(p11;q32) CRLF2-IGH translocations from human B-lineage ALLs involve CpG-type breaks at CRLF2, but CRLF2/P2RY8 intrachromosomal deletions do not. Blood, 116, 11, 1993-4 Blood, 116, 11, 1993-4 Blood, 116, 11, 1993-4 2010/09/16 Refereed English Disclose to all
Libi Hertzberg, Elena Vendramini, Ithamar Ganmore, Gianni Cazzaniga, Maike Schmitz, Jane Chalker, Ruth Shiloh, Ilaria Iacobucci, Chen Shochat, Sharon Zeligson, Gunnar Cario, Martin Stanulla, Sabine Strehl, Lisa J Russell, Christine J Harrison, Beat Bornhauser, Akinori Yoda, Gideon Rechavi, Dani Bercovich, Arndt Borkhardt, Helena Kempski, Geertruy te Kronnie, Jean-Pierre Bourquin, Eytan Domany, Shai Izraeli Libi Hertzberg, Elena Vendramini, Ithamar Ganmore, Gianni Cazzaniga, Maike Schmitz, Jane Chalker, Ruth Shiloh, Ilaria Iacobucci, Chen Shochat, Sharon Zeligson, Gunnar Cario, Martin Stanulla, Sabine Strehl, Lisa J Russell, Christine J Harrison, Beat Bornhauser, Akinori Yoda, Gideon Rechavi, Dani Bercovich, Arndt Borkhardt, Helena Kempski, Geertruy te Kronnie, Jean-Pierre Bourquin, Eytan Domany, Shai Izraeli Libi Hertzberg, Elena Vendramini, Ithamar Ganmore, Gianni Cazzaniga, Maike Schmitz, Jane Chalker, Ruth Shiloh, Ilaria Iacobucci, Chen Shochat, Sharon Zeligson, Gunnar Cario, Martin Stanulla, Sabine Strehl, Lisa J Russell, Christine J Harrison, Beat Bornhauser, Akinori Yoda, Gideon Rechavi, Dani Bercovich, Arndt Borkhardt, Helena Kempski, Geertruy te Kronnie, Jean-Pierre Bourquin, Eytan Domany, Shai Izraeli Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group. Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group. Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group. Blood, 115, 5, 1006-17 Blood, 115, 5, 1006-17 Blood, 115, 5, 1006-17 2010/02/04 Refereed English Research paper(scientific journal) Disclose to all
Akinori Yoda, Yuka Yoda, Sabina Chiaretti, Michal Bar-Natan, Kartik Mani, Scott J Rodig, Nathan West, Yun Xiao, Jennifer R Brown, Constantine Mitsiades, Martin Sattler, Jeffrey L Kutok, Daniel J DeAngelo, Martha Wadleigh, Alfonso Piciocchi, Paola Dal Cin, James E Bradner, James D Griffin, Kenneth C Anderson, Richard M Stone, Jerome Ritz, Robin Foà, Jon C Aster, David A Frank, David M Weinstock Akinori Yoda, Yuka Yoda, Sabina Chiaretti, Michal Bar-Natan, Kartik Mani, Scott J Rodig, Nathan West, Yun Xiao, Jennifer R Brown, Constantine Mitsiades, Martin Sattler, Jeffrey L Kutok, Daniel J DeAngelo, Martha Wadleigh, Alfonso Piciocchi, Paola Dal Cin, James E Bradner, James D Griffin, Kenneth C Anderson, Richard M Stone, Jerome Ritz, Robin Foà, Jon C Aster, David A Frank, David M Weinstock Akinori Yoda, Yuka Yoda, Sabina Chiaretti, Michal Bar-Natan, Kartik Mani, Scott J Rodig, Nathan West, Yun Xiao, Jennifer R Brown, Constantine Mitsiades, Martin Sattler, Jeffrey L Kutok, Daniel J DeAngelo, Martha Wadleigh, Alfonso Piciocchi, Paola Dal Cin, James E Bradner, James D Griffin, Kenneth C Anderson, Richard M Stone, Jerome Ritz, Robin Foà, Jon C Aster, David A Frank, David M Weinstock Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia. Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia. Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia. Proceedings of the National Academy of Sciences of the United States of America, 107, 1, 252-7 Proceedings of the National Academy of Sciences of the United States of America, 107, 1, 252-7 Proceedings of the National Academy of Sciences of the United States of America, 107, 1, 252-7 2010/01/05 Refereed English Research paper(scientific journal) Disclose to all
Akinori Yoda, Kyoko Toyoshima, Yasuhide Watanabe, Nobuyuki Onishi, Yuki Hazaka, Yusuke Tsukuda, Junichi Tsukada, Takeshi Kondo, Yoshiya Tanaka, Yasuhiro Minami Akinori Yoda, Kyoko Toyoshima, Yasuhide Watanabe, Nobuyuki Onishi, Yuki Hazaka, Yusuke Tsukuda, Junichi Tsukada, Takeshi Kondo, Yoshiya Tanaka, Yasuhiro Minami Akinori Yoda, Kyoko Toyoshima, Yasuhide Watanabe, Nobuyuki Onishi, Yuki Hazaka, Yusuke Tsukuda, Junichi Tsukada, Takeshi Kondo, Yoshiya Tanaka, Yasuhiro Minami Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase. Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase. Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase. The Journal of biological chemistry, 283, 27, 18969-79 The Journal of biological chemistry, 283, 27, 18969-79 The Journal of biological chemistry, 283, 27, 18969-79 2008/07/04 Refereed English Research paper(scientific journal) Disclose to all
Sa Kan Yoo, Nobuyuki Onishi, Naoko Kato, Akinori Yoda, Yasuhiro Minami Sa Kan Yoo, Nobuyuki Onishi, Naoko Kato, Akinori Yoda, Yasuhiro Minami Sa Kan Yoo, Nobuyuki Onishi, Naoko Kato, Akinori Yoda, Yasuhiro Minami [Relationship between abnormalities of genes involved in DNA damage responses and malignant tumors/autoimmune diseases]. [Relationship between abnormalities of genes involved in DNA damage responses and malignant tumors/autoimmune diseases]. [Relationship between abnormalities of genes involved in DNA damage responses and malignant tumors/autoimmune diseases]. Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 29, 3, 136-47 Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 29, 3, 136-47 Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 29, 3, 136-47 2006/06 Refereed Japanese Research paper(scientific journal) Disclose to all
Maureen Wirschell, Gregory Pazour, Akinori Yoda, Masafumi Hirono, Ritsu Kamiya, George B Witman Maureen Wirschell, Gregory Pazour, Akinori Yoda, Masafumi Hirono, Ritsu Kamiya, George B Witman Maureen Wirschell, Gregory Pazour, Akinori Yoda, Masafumi Hirono, Ritsu Kamiya, George B Witman Oda5p, a novel axonemal protein required for assembly of the outer dynein arm and an associated adenylate kinase. Oda5p, a novel axonemal protein required for assembly of the outer dynein arm and an associated adenylate kinase. Oda5p, a novel axonemal protein required for assembly of the outer dynein arm and an associated adenylate kinase. Molecular biology of the cell, 15, 6, 2729-41 Molecular biology of the cell, 15, 6, 2729-41 Molecular biology of the cell, 15, 6, 2729-41 2004/06 Refereed English Research paper(scientific journal) Disclose to all
M Nomi, Oishi, I, S Kani, H Suzuki, T Matsuda, A Yoda, M Kitamura, K Itoh, S Takeuchi, K Takeda, S Akira, M Ikeya, S Takada, Y Minami M Nomi, Oishi, I, S Kani, H Suzuki, T Matsuda, A Yoda, M Kitamura, K Itoh, S Takeuchi, K Takeda, S Akira, M Ikeya, S Takada, Y Minami M Nomi, Oishi, I, S Kani, H Suzuki, T Matsuda, A Yoda, M Kitamura, K Itoh, S Takeuchi, K Takeda, S Akira, M Ikeya, S Takada, Y Minami Loss of mRor1 enhances the heart and skeletal abnormalities in mRor2-deficient mice: Redundant and pleiotropic functions of mRor1 and mRor2 receptor tyrosine kinases Loss of mRor1 enhances the heart and skeletal abnormalities in mRor2-deficient mice: Redundant and pleiotropic functions of mRor1 and mRor2 receptor tyrosine kinases Loss of mRor1 enhances the heart and skeletal abnormalities in mRor2-deficient mice: Redundant and pleiotropic functions of mRor1 and mRor2 receptor tyrosine kinases MOLECULAR AND CELLULAR BIOLOGY, 21, 24, 8329-8335 MOLECULAR AND CELLULAR BIOLOGY, 21, 24, 8329-8335 MOLECULAR AND CELLULAR BIOLOGY, 21, 24, 8329-8335 2001/12 Refereed English Research paper(scientific journal) Disclose to all
Yoda A, Sawa H, Okano H Yoda A, Sawa H, Okano H Yoda A, Sawa H, Okano H MSI-1, a neural RNA-binding protein, is involved in male mating behaviour in Caenorhabditis elegans. MSI-1, a neural RNA-binding protein, is involved in male mating behaviour in Caenorhabditis elegans. MSI-1, a neural RNA-binding protein, is involved in male mating behaviour in Caenorhabditis elegans. Genes to cells : devoted to molecular & cellular mechanisms, 5, 885-895 Genes to cells : devoted to molecular & cellular mechanisms, 5, 885-895 Genes to cells : devoted to molecular & cellular mechanisms, 5, 885-895 2000/11 Refereed Disclose to all
Good Peter, Yoda Akinori, Sakakibara Shin Ichi, Yamamoto Atsuyo, Imai Takao, Sawa Hitoshi, Ikeuchi Takeshi, Tsuji Shoji, Satoh Hitoshi, Okano Hideyuki Good Peter, Yoda Akinori, Sakakibara Shin Ichi, Yamamoto Atsuyo, Imai Takao, Sawa Hitoshi, Ikeuchi Takeshi, Tsuji Shoji, Satoh Hitoshi, Okano Hideyuki Good Peter, Yoda Akinori, Sakakibara Shin Ichi, Yamamoto Atsuyo, Imai Takao, Sawa Hitoshi, Ikeuchi Takeshi, Tsuji Shoji, Satoh Hitoshi, Okano Hideyuki The human Musashi homolog 1 (MSI1) gene encoding the homologue of Musashi/Nrp-1, a neural RNA-binding protein putatively expressed in CNS stem cells and neural progenitor cells The human Musashi homolog 1 (MSI1) gene encoding the homologue of Musashi/Nrp-1, a neural RNA-binding protein putatively expressed in CNS stem cells and neural progenitor cells The human Musashi homolog 1 (MSI1) gene encoding the homologue of Musashi/Nrp-1, a neural RNA-binding protein putatively expressed in CNS stem cells and neural progenitor cells Genomics, 52, 3, 382-384 Genomics, 52, 3, 382-384 Genomics, 52, 3, 382-384 1998/09/15 English Disclose to all

  • <<
  • >>
Title language:
Misc
Author Author(Japanese) Author(English) Title Title(Japanese) Title(English) Bibliography Bibliography(Japanese) Bibliography(English) Publication date Refereed paper Language Publishing type Disclose
Loretta S. Li, Nadja Kopp, Shuo-Chieh Wu, Jordy Van Der Zwet, Jacob V. Layer, Oliver Weigert, Amanda L. Christie, Alexandra N. Christodoulou, Huiyun Liu, Akinori Yoda, Thomas Radimerski, David M. Weinstock Loretta S. Li, Nadja Kopp, Shuo-Chieh Wu, Jordy Van Der Zwet, Jacob V. Layer, Oliver Weigert, Amanda L. Christie, Alexandra N. Christodoulou, Huiyun Liu, Akinori Yoda, Thomas Radimerski, David M. Weinstock Loretta S. Li, Nadja Kopp, Shuo-Chieh Wu, Jordy Van Der Zwet, Jacob V. Layer, Oliver Weigert, Amanda L. Christie, Alexandra N. Christodoulou, Huiyun Liu, Akinori Yoda, Thomas Radimerski, David M. Weinstock Type II JAK2 inhibitor NVP-CHZ868 has potent activity in JAK2-dependent B-cell acute lymphoblastic leukemias (B-ALLs) in vivo. Type II JAK2 inhibitor NVP-CHZ868 has potent activity in JAK2-dependent B-cell acute lymphoblastic leukemias (B-ALLs) in vivo. Type II JAK2 inhibitor NVP-CHZ868 has potent activity in JAK2-dependent B-cell acute lymphoblastic leukemias (B-ALLs) in vivo. CLINICAL CANCER RESEARCH, 21 CLINICAL CANCER RESEARCH, 21 CLINICAL CANCER RESEARCH, 21 2015/09 English Research paper, summary (international conference) Disclose to all
Loretta S. Li, Shuo-Chieh Wu, Nadja Kopp, Joan Montero, Jeremy Ryan, Bjoern Chapuy, Jordy C. Van der Zwet, Jacob Layer, Oliver Weigert, Amanda L. Christie, Alexandra N. Christodoulou, Huiyun Liu, Akinori Yoda, Francesco Hofmann, Fabienne Baffert, Eric Vangrevelinghe, Christoph Gaul, Thomas Radimerski, Anthony G. Letai, David M. Weinstock Loretta S. Li, Shuo-Chieh Wu, Nadja Kopp, Joan Montero, Jeremy Ryan, Bjoern Chapuy, Jordy C. Van der Zwet, Jacob Layer, Oliver Weigert, Amanda L. Christie, Alexandra N. Christodoulou, Huiyun Liu, Akinori Yoda, Francesco Hofmann, Fabienne Baffert, Eric Vangrevelinghe, Christoph Gaul, Thomas Radimerski, Anthony G. Letai, David M. Weinstock Loretta S. Li, Shuo-Chieh Wu, Nadja Kopp, Joan Montero, Jeremy Ryan, Bjoern Chapuy, Jordy C. Van der Zwet, Jacob Layer, Oliver Weigert, Amanda L. Christie, Alexandra N. Christodoulou, Huiyun Liu, Akinori Yoda, Francesco Hofmann, Fabienne Baffert, Eric Vangrevelinghe, Christoph Gaul, Thomas Radimerski, Anthony G. Letai, David M. Weinstock Type II JAK2 Inhibitor NVP-CHZ868 Is Active in Vivo Against JAK2-Dependent B-Cell Acute Lymphoblastic Leukemias (B-ALLs) Type II JAK2 Inhibitor NVP-CHZ868 Is Active in Vivo Against JAK2-Dependent B-Cell Acute Lymphoblastic Leukemias (B-ALLs) Type II JAK2 Inhibitor NVP-CHZ868 Is Active in Vivo Against JAK2-Dependent B-Cell Acute Lymphoblastic Leukemias (B-ALLs) BLOOD, 124, 21 BLOOD, 124, 21 BLOOD, 124, 21 2014/12 English Research paper, summary (international conference) Disclose to all
Akinori Yoda, Guillaume Adelmant, Jerome Tamburini, Bjoern Chapuy, Nobuaki Shindoh, Yuka Yoda, Oliver Weigert, Nadja Kopp, Shuo-Chieh Wu, Sunhee S. Kim, Huiyun Liu, Trevor Tivey, Amanda L. Christie, Kutlu G. Elpek, Joseph Card, Kira Gritsman, Jason Gotlib, Michael W. Deininger, Hideki Makishima, Shannon Turley, Nathalie Javidi-Sharifi, Jaroslaw P. Maciejewski, Scott J. Rodig, Jeffrey W. Tyner, Jarrod A. Marto, David M. Weinstock, Andrew A. Lane Akinori Yoda, Guillaume Adelmant, Jerome Tamburini, Bjoern Chapuy, Nobuaki Shindoh, Yuka Yoda, Oliver Weigert, Nadja Kopp, Shuo-Chieh Wu, Sunhee S. Kim, Huiyun Liu, Trevor Tivey, Amanda L. Christie, Kutlu G. Elpek, Joseph Card, Kira Gritsman, Jason Gotlib, Michael W. Deininger, Hideki Makishima, Shannon Turley, Nathalie Javidi-Sharifi, Jaroslaw P. Maciejewski, Scott J. Rodig, Jeffrey W. Tyner, Jarrod A. Marto, David M. Weinstock, Andrew A. Lane Akinori Yoda, Guillaume Adelmant, Jerome Tamburini, Bjoern Chapuy, Nobuaki Shindoh, Yuka Yoda, Oliver Weigert, Nadja Kopp, Shuo-Chieh Wu, Sunhee S. Kim, Huiyun Liu, Trevor Tivey, Amanda L. Christie, Kutlu G. Elpek, Joseph Card, Kira Gritsman, Jason Gotlib, Michael W. Deininger, Hideki Makishima, Shannon Turley, Nathalie Javidi-Sharifi, Jaroslaw P. Maciejewski, Scott J. Rodig, Jeffrey W. Tyner, Jarrod A. Marto, David M. Weinstock, Andrew A. Lane GNB1 Activating Mutations Promote Myeloid and Lymphoid Neoplasms Targetable By Combined PI3K/mTOR Inhibition GNB1 Activating Mutations Promote Myeloid and Lymphoid Neoplasms Targetable By Combined PI3K/mTOR Inhibition GNB1 Activating Mutations Promote Myeloid and Lymphoid Neoplasms Targetable By Combined PI3K/mTOR Inhibition BLOOD, 124, 21 BLOOD, 124, 21 BLOOD, 124, 21 2014/12 English Research paper, summary (international conference) Disclose to all
Andrew A. Lane, Bjoern Chapuy, Charles Y. Lin, Trevor Tivey, Hubo Li, Elizabeth Townsend, Diederik van Bodegom, Tovah A. Day, Shuo-Chieh Wu, Huiyun Liu, Akinori Yoda, Gabriela Alexe, Anna Schinzel, Timothy J. Sullivan, Sebastien Malinge, Jordan Taylor, Kimberly Stegmaier, Jacob Jaffe, Michael Bustin, Geertruy te Kronnie, Shai Izraeli, Marian Harris, Kristen Stevenson, Donna Neuberg, Lewis B. Silverman, Steven E. Sallan, James E. Bradner, William C. Hahn, John D. Crispino, David Pellman, David M. Weinstock Andrew A. Lane, Bjoern Chapuy, Charles Y. Lin, Trevor Tivey, Hubo Li, Elizabeth Townsend, Diederik van Bodegom, Tovah A. Day, Shuo-Chieh Wu, Huiyun Liu, Akinori Yoda, Gabriela Alexe, Anna Schinzel, Timothy J. Sullivan, Sebastien Malinge, Jordan Taylor, Kimberly Stegmaier, Jacob Jaffe, Michael Bustin, Geertruy te Kronnie, Shai Izraeli, Marian Harris, Kristen Stevenson, Donna Neuberg, Lewis B. Silverman, Steven E. Sallan, James E. Bradner, William C. Hahn, John D. Crispino, David Pellman, David M. Weinstock Andrew A. Lane, Bjoern Chapuy, Charles Y. Lin, Trevor Tivey, Hubo Li, Elizabeth Townsend, Diederik van Bodegom, Tovah A. Day, Shuo-Chieh Wu, Huiyun Liu, Akinori Yoda, Gabriela Alexe, Anna Schinzel, Timothy J. Sullivan, Sebastien Malinge, Jordan Taylor, Kimberly Stegmaier, Jacob Jaffe, Michael Bustin, Geertruy te Kronnie, Shai Izraeli, Marian Harris, Kristen Stevenson, Donna Neuberg, Lewis B. Silverman, Steven E. Sallan, James E. Bradner, William C. Hahn, John D. Crispino, David Pellman, David M. Weinstock Triplication of HMGN1 promotes B cell acute lymphoblastic leukemia (B-ALL) through suppression of H3K27me3 Triplication of HMGN1 promotes B cell acute lymphoblastic leukemia (B-ALL) through suppression of H3K27me3 Triplication of HMGN1 promotes B cell acute lymphoblastic leukemia (B-ALL) through suppression of H3K27me3 CANCER RESEARCH, 74, 19 CANCER RESEARCH, 74, 19 CANCER RESEARCH, 74, 19 2014/10 English Research paper, summary (international conference) Disclose to all
Justin Taylor, Sunhee S. Kim, Kristen E. Stevenson, Akinori Yoda, Nadja Kopp, Abner Louissaint, Nancy Lee Harris, Ephraim P. Hochberg, Yi-Bin Chen, Scott B. Lovitch, Daniel J. DeAngelo, Martha Wadleigh, David P. Steensma, Gabriela Motyckova, Richard M. Stone, Donna S. Neuberg, Fabrice Jardin, Pier Paolo Piccaluga, David M. Weinstock, Andrew A. Lane Justin Taylor, Sunhee S. Kim, Kristen E. Stevenson, Akinori Yoda, Nadja Kopp, Abner Louissaint, Nancy Lee Harris, Ephraim P. Hochberg, Yi-Bin Chen, Scott B. Lovitch, Daniel J. DeAngelo, Martha Wadleigh, David P. Steensma, Gabriela Motyckova, Richard M. Stone, Donna S. Neuberg, Fabrice Jardin, Pier Paolo Piccaluga, David M. Weinstock, Andrew A. Lane Justin Taylor, Sunhee S. Kim, Kristen E. Stevenson, Akinori Yoda, Nadja Kopp, Abner Louissaint, Nancy Lee Harris, Ephraim P. Hochberg, Yi-Bin Chen, Scott B. Lovitch, Daniel J. DeAngelo, Martha Wadleigh, David P. Steensma, Gabriela Motyckova, Richard M. Stone, Donna S. Neuberg, Fabrice Jardin, Pier Paolo Piccaluga, David M. Weinstock, Andrew A. Lane Loss-Of-Function Mutations In The Splicing Factor ZRSR2 Are Common In Blastic Plasmacytoid Dendritic Cell Neoplasm and Have Male Predominance Loss-Of-Function Mutations In The Splicing Factor ZRSR2 Are Common In Blastic Plasmacytoid Dendritic Cell Neoplasm and Have Male Predominance Loss-Of-Function Mutations In The Splicing Factor ZRSR2 Are Common In Blastic Plasmacytoid Dendritic Cell Neoplasm and Have Male Predominance BLOOD, 122, 21 BLOOD, 122, 21 BLOOD, 122, 21 2013/11 English Research paper, summary (international conference) Disclose to all
Akinori Yoda, Guillaume Adelmant, Nobuaki Shindoh, Bjoern Chapuy, Yuka Yoda, Oliver Weigert, Nadja Kopp, Shuo-Chieh Wu, Sunhee S. Kim, Huiyun Liu, Trevor Tivey, Jeffrey W. Tyner, Jason Gotlib, Michael W. Deininger, Shannon Turley, Jarrod A. Marto, Andrew A. Lane, David M. Weinstock Akinori Yoda, Guillaume Adelmant, Nobuaki Shindoh, Bjoern Chapuy, Yuka Yoda, Oliver Weigert, Nadja Kopp, Shuo-Chieh Wu, Sunhee S. Kim, Huiyun Liu, Trevor Tivey, Jeffrey W. Tyner, Jason Gotlib, Michael W. Deininger, Shannon Turley, Jarrod A. Marto, Andrew A. Lane, David M. Weinstock Akinori Yoda, Guillaume Adelmant, Nobuaki Shindoh, Bjoern Chapuy, Yuka Yoda, Oliver Weigert, Nadja Kopp, Shuo-Chieh Wu, Sunhee S. Kim, Huiyun Liu, Trevor Tivey, Jeffrey W. Tyner, Jason Gotlib, Michael W. Deininger, Shannon Turley, Jarrod A. Marto, Andrew A. Lane, David M. Weinstock The Beta-Subunit Of Heterotrimeric G Proteins Harbors Gain-Of-Function Mutations In Multiple Hematologic Malignancies The Beta-Subunit Of Heterotrimeric G Proteins Harbors Gain-Of-Function Mutations In Multiple Hematologic Malignancies The Beta-Subunit Of Heterotrimeric G Proteins Harbors Gain-Of-Function Mutations In Multiple Hematologic Malignancies BLOOD, 122, 21 BLOOD, 122, 21 BLOOD, 122, 21 2013/11 English Research paper, summary (international conference) Disclose to all
Oliver Weigert, Nadja Kopp, Andrew A. Lane, Akinori Yoda, Suzanne E. Dahlberg, Donna Neuberg, Anita Y. Bahar, Bjoern Chapuy, Frank Kuo, Terry Haley, Timothy J. Sullivan, Edward Fox, Scott J. Rodig, Joseph H. Antin, David M. Weinstock Oliver Weigert, Nadja Kopp, Andrew A. Lane, Akinori Yoda, Suzanne E. Dahlberg, Donna Neuberg, Anita Y. Bahar, Bjoern Chapuy, Frank Kuo, Terry Haley, Timothy J. Sullivan, Edward Fox, Scott J. Rodig, Joseph H. Antin, David M. Weinstock Oliver Weigert, Nadja Kopp, Andrew A. Lane, Akinori Yoda, Suzanne E. Dahlberg, Donna Neuberg, Anita Y. Bahar, Bjoern Chapuy, Frank Kuo, Terry Haley, Timothy J. Sullivan, Edward Fox, Scott J. Rodig, Joseph H. Antin, David M. Weinstock Molecular Ontogeny of Donor-Derived Lymphomas Occurring After Transplantation Molecular Ontogeny of Donor-Derived Lymphomas Occurring After Transplantation Molecular Ontogeny of Donor-Derived Lymphomas Occurring After Transplantation BLOOD, 118, 21, 1569-1569 BLOOD, 118, 21, 1569-1569 BLOOD, 118, 21, 1569-1569 2011/11 English Research paper, summary (international conference) Disclose to all
Oliver Weigert, Liat Bird, Nadja Kopp, Andrew A. Lane, Bjoern Chapuy, Diederik van Bodegom, Sachie Marubayashi, Akinori Yoda, Vincent Romanet, Masato Murakami, Stephen E. Sallan, Ross L. Levine, Andrew L. Kung, Thomas Radimerski, David M. Weinstock Oliver Weigert, Liat Bird, Nadja Kopp, Andrew A. Lane, Bjoern Chapuy, Diederik van Bodegom, Sachie Marubayashi, Akinori Yoda, Vincent Romanet, Masato Murakami, Stephen E. Sallan, Ross L. Levine, Andrew L. Kung, Thomas Radimerski, David M. Weinstock Oliver Weigert, Liat Bird, Nadja Kopp, Andrew A. Lane, Bjoern Chapuy, Diederik van Bodegom, Sachie Marubayashi, Akinori Yoda, Vincent Romanet, Masato Murakami, Stephen E. Sallan, Ross L. Levine, Andrew L. Kung, Thomas Radimerski, David M. Weinstock HSP90 Inhibition Targets JAK2 and Is Highly Effective in CRLF2-Rearranged Acute Lymphoblastic Leukemia HSP90 Inhibition Targets JAK2 and Is Highly Effective in CRLF2-Rearranged Acute Lymphoblastic Leukemia HSP90 Inhibition Targets JAK2 and Is Highly Effective in CRLF2-Rearranged Acute Lymphoblastic Leukemia BLOOD, 118, 21, 265-266 BLOOD, 118, 21, 265-266 BLOOD, 118, 21, 265-266 2011/11 English Research paper, summary (international conference) Disclose to all
Oliver Weigert, Andrew Lane, Nadja Kopp, Scott Rodig, Akinori Yoda, David M. Weinstock Oliver Weigert, Andrew Lane, Nadja Kopp, Scott Rodig, Akinori Yoda, David M. Weinstock Oliver Weigert, Andrew Lane, Nadja Kopp, Scott Rodig, Akinori Yoda, David M. Weinstock Functional oncogene identification in hematologic malignancies Functional oncogene identification in hematologic malignancies Functional oncogene identification in hematologic malignancies CANCER RESEARCH, 71 CANCER RESEARCH, 71 CANCER RESEARCH, 71 2011/04 English Research paper, summary (international conference) Disclose to all
Akinori Yoda, Terry Haley, Oliver B. Weigert, Jeffery Kutok, Adalis Maisonet, Maura Salois, Edward Fox, David M. Weinstock Akinori Yoda, Terry Haley, Oliver B. Weigert, Jeffery Kutok, Adalis Maisonet, Maura Salois, Edward Fox, David M. Weinstock Akinori Yoda, Terry Haley, Oliver B. Weigert, Jeffery Kutok, Adalis Maisonet, Maura Salois, Edward Fox, David M. Weinstock Next Generation Sequencing Identifies Novel Oncogene Alterations In CRLF2-rearranged Precursor B-Cell Acute Lymphoblastic Leukemia Next Generation Sequencing Identifies Novel Oncogene Alterations In CRLF2-rearranged Precursor B-Cell Acute Lymphoblastic Leukemia Next Generation Sequencing Identifies Novel Oncogene Alterations In CRLF2-rearranged Precursor B-Cell Acute Lymphoblastic Leukemia BLOOD, 116, 21, 210-211 BLOOD, 116, 21, 210-211 BLOOD, 116, 21, 210-211 2010/11 English Research paper, summary (international conference) Disclose to all
Kartik Mani, Akinori Yoda, Sabina Chiaretti, Robin Foa, David M. Weinstock Kartik Mani, Akinori Yoda, Sabina Chiaretti, Robin Foa, David M. Weinstock Kartik Mani, Akinori Yoda, Sabina Chiaretti, Robin Foa, David M. Weinstock CRLF2/JAK Signaling in Adult and Pediatric Acute Lymphoblastic Leukemia Is Highly Similar to BCR/ABL. CRLF2/JAK Signaling in Adult and Pediatric Acute Lymphoblastic Leukemia Is Highly Similar to BCR/ABL. CRLF2/JAK Signaling in Adult and Pediatric Acute Lymphoblastic Leukemia Is Highly Similar to BCR/ABL. BLOOD, 114, 22, 1344-1344 BLOOD, 114, 22, 1344-1344 BLOOD, 114, 22, 1344-1344 2009/11 English Research paper, summary (international conference) Disclose to all
David M. Miller, Akinori Yoda, Yuka Yoda, David M. Weinstock David M. Miller, Akinori Yoda, Yuka Yoda, David M. Weinstock David M. Miller, Akinori Yoda, Yuka Yoda, David M. Weinstock Mechanisms of CRLF2 Rearrangement with IGH and P2RY8 in B-Cell Acute Lymphoblastic Leukemia Mechanisms of CRLF2 Rearrangement with IGH and P2RY8 in B-Cell Acute Lymphoblastic Leukemia Mechanisms of CRLF2 Rearrangement with IGH and P2RY8 in B-Cell Acute Lymphoblastic Leukemia BLOOD, 114, 22, 1256-1257 BLOOD, 114, 22, 1256-1257 BLOOD, 114, 22, 1256-1257 2009/11 English Research paper, summary (international conference) Disclose to all
Libi Hertzberg, Elena Vendramini, Ithamar Ganmore, Giovanni Cazzaniga, Maike Schmitz, Ruth Shiloh, Jane Chalker, Ilaria Iacobucci, Chen Shochat, Sharon Zeligson, Gunnar Cario, Martin Stanulla, Sabine Strehl, Lisa J. Russel, Christine Harrison, Beat Bornhauser, Akinori Yoda, Gideon Rechavi, Dani Bercovich, Arndt Borkardt, Helena Kempski, Geertruy te Kronnie, Jean-Pierre Bourquin, Eytan Domany, Shai Izraeli Libi Hertzberg, Elena Vendramini, Ithamar Ganmore, Giovanni Cazzaniga, Maike Schmitz, Ruth Shiloh, Jane Chalker, Ilaria Iacobucci, Chen Shochat, Sharon Zeligson, Gunnar Cario, Martin Stanulla, Sabine Strehl, Lisa J. Russel, Christine Harrison, Beat Bornhauser, Akinori Yoda, Gideon Rechavi, Dani Bercovich, Arndt Borkardt, Helena Kempski, Geertruy te Kronnie, Jean-Pierre Bourquin, Eytan Domany, Shai Izraeli Libi Hertzberg, Elena Vendramini, Ithamar Ganmore, Giovanni Cazzaniga, Maike Schmitz, Ruth Shiloh, Jane Chalker, Ilaria Iacobucci, Chen Shochat, Sharon Zeligson, Gunnar Cario, Martin Stanulla, Sabine Strehl, Lisa J. Russel, Christine Harrison, Beat Bornhauser, Akinori Yoda, Gideon Rechavi, Dani Bercovich, Arndt Borkardt, Helena Kempski, Geertruy te Kronnie, Jean-Pierre Bourquin, Eytan Domany, Shai Izraeli DOWN&apos;S Syndrome Acute Lymphoblastic LEUKEMIA: A HIGHLY Heterogeneous DISEASE DRIVEN by an Aberrant CRLF2/JAK2 Cooperation - A REPORT FROM the Ibfm-STUDY GROUP DOWN&apos;S Syndrome Acute Lymphoblastic LEUKEMIA: A HIGHLY Heterogeneous DISEASE DRIVEN by an Aberrant CRLF2/JAK2 Cooperation - A REPORT FROM the Ibfm-STUDY GROUP DOWN&apos;S Syndrome Acute Lymphoblastic LEUKEMIA: A HIGHLY Heterogeneous DISEASE DRIVEN by an Aberrant CRLF2/JAK2 Cooperation - A REPORT FROM the Ibfm-STUDY GROUP BLOOD, 114, 22, 10-10 BLOOD, 114, 22, 10-10 BLOOD, 114, 22, 10-10 2009/11 English Research paper, summary (international conference) Disclose to all
C. Nathan West, Akinori Yoda, Sabina Chiaretti, Kartik Mani, Robin Foa, James Bradner, David M. Weinstock C. Nathan West, Akinori Yoda, Sabina Chiaretti, Kartik Mani, Robin Foa, James Bradner, David M. Weinstock C. Nathan West, Akinori Yoda, Sabina Chiaretti, Kartik Mani, Robin Foa, James Bradner, David M. Weinstock CRLF2/JAK Signaling Confers Susceptibility to JAK Inhibitors and Small Molecule Inhibitors of Protein Kinase C. CRLF2/JAK Signaling Confers Susceptibility to JAK Inhibitors and Small Molecule Inhibitors of Protein Kinase C. CRLF2/JAK Signaling Confers Susceptibility to JAK Inhibitors and Small Molecule Inhibitors of Protein Kinase C. BLOOD, 114, 22, 1450-1450 BLOOD, 114, 22, 1450-1450 BLOOD, 114, 22, 1450-1450 2009/11 English Research paper, summary (international conference) Disclose to all
Akinori Yoda, Michal Bar-Natan, Martin Sattler, Jerome Ritz, David Frank, David Weinstock Akinori Yoda, Michal Bar-Natan, Martin Sattler, Jerome Ritz, David Frank, David Weinstock Akinori Yoda, Michal Bar-Natan, Martin Sattler, Jerome Ritz, David Frank, David Weinstock CRLF2 is a proto-oncogene in pre-B acute lymphoblastic leukemia with normal cytogenetics CRLF2 is a proto-oncogene in pre-B acute lymphoblastic leukemia with normal cytogenetics CRLF2 is a proto-oncogene in pre-B acute lymphoblastic leukemia with normal cytogenetics CANCER RESEARCH, 69 CANCER RESEARCH, 69 CANCER RESEARCH, 69 2009/05 English Research paper, summary (international conference) Disclose to all
Shuichi Kani, Emiko Nakayama, Akinori Yoda, Nobuyuki Onishi, Nagako Sougawa, Yuki Hazaka, Tsuyoshi Umeda, Kohsuke Takeda, Hidenori Ichijo, Yasuhiro Hamada, Yasuhiro Minami Shuichi Kani, Emiko Nakayama, Akinori Yoda, Nobuyuki Onishi, Nagako Sougawa, Yuki Hazaka, Tsuyoshi Umeda, Kohsuke Takeda, Hidenori Ichijo, Yasuhiro Hamada, Yasuhiro Minami Shuichi Kani, Emiko Nakayama, Akinori Yoda, Nobuyuki Onishi, Nagako Sougawa, Yuki Hazaka, Tsuyoshi Umeda, Kohsuke Takeda, Hidenori Ichijo, Yasuhiro Hamada, Yasuhiro Minami Chk2 kinase is required for methylglyoxal-induced G(2)/M cell-cycle checkpoint arrest: implication of cell-cycle checkpoint regulation in diabetic oxidative stress signaling Chk2 kinase is required for methylglyoxal-induced G(2)/M cell-cycle checkpoint arrest: implication of cell-cycle checkpoint regulation in diabetic oxidative stress signaling Chk2 kinase is required for methylglyoxal-induced G(2)/M cell-cycle checkpoint arrest: implication of cell-cycle checkpoint regulation in diabetic oxidative stress signaling GENES TO CELLS, 12, 8, 919-928 GENES TO CELLS, 12, 8, 919-928 GENES TO CELLS, 12, 8, 919-928 2007/08 English Disclose to all
Shuichi Kani, Emiko Nakayama, Akinori Yoda, Nobuyuki Onishi, Nagako Sougawa, Yuki Hazaka, Tsuyoshi Umeda, Kohsuke Takeda, Hidenori Ichijo, Yasuhiro Hamada, Yasuhiro Minami Shuichi Kani, Emiko Nakayama, Akinori Yoda, Nobuyuki Onishi, Nagako Sougawa, Yuki Hazaka, Tsuyoshi Umeda, Kohsuke Takeda, Hidenori Ichijo, Yasuhiro Hamada, Yasuhiro Minami Shuichi Kani, Emiko Nakayama, Akinori Yoda, Nobuyuki Onishi, Nagako Sougawa, Yuki Hazaka, Tsuyoshi Umeda, Kohsuke Takeda, Hidenori Ichijo, Yasuhiro Hamada, Yasuhiro Minami Chk2 kinase is required for methylglyoxal-induced G2/M cell-cycle checkpoint arrest: implication of cell-cycle checkpoint regulation in diabetic oxidative stress signaling. Chk2 kinase is required for methylglyoxal-induced G2/M cell-cycle checkpoint arrest: implication of cell-cycle checkpoint regulation in diabetic oxidative stress signaling. Chk2 kinase is required for methylglyoxal-induced G2/M cell-cycle checkpoint arrest: implication of cell-cycle checkpoint regulation in diabetic oxidative stress signaling. Genes to cells : devoted to molecular & cellular mechanisms, 12, 8, 919-28 Genes to cells : devoted to molecular & cellular mechanisms, 12, 8, 919-28 Genes to cells : devoted to molecular & cellular mechanisms, 12, 8, 919-28 2007/08 English Disclose to all
DNA損傷時におけるChk1/Chk2によるWip1のリン酸化および安定化制御(Chk1/Chk2 phosphorylates and stabilizes Wip1 in response to DNA damage)(英語) DNA損傷時におけるChk1/Chk2によるWip1のリン酸化および安定化制御(Chk1/Chk2 phosphorylates and stabilizes Wip1 in response to DNA damage)(英語) 日本癌学会総会記事, -巻, 66回, pp. 487-487 日本癌学会総会記事, -巻, 66回, pp. 487-487 , -巻, 66回, pp. 487-487 2007 Disclose to all
Akinori Yoda, Xiao Zhou Xu, Nobuyuki Onishi, Kyoko Toyoshima, Hiroko Fujimoto, Naoko Kato, Isao Oishi, Takeshi Kondo, Yasuhiro Minami Akinori Yoda, Xiao Zhou Xu, Nobuyuki Onishi, Kyoko Toyoshima, Hiroko Fujimoto, Naoko Kato, Isao Oishi, Takeshi Kondo, Yasuhiro Minami Akinori Yoda, Xiao Zhou Xu, Nobuyuki Onishi, Kyoko Toyoshima, Hiroko Fujimoto, Naoko Kato, Isao Oishi, Takeshi Kondo, Yasuhiro Minami Intrinsic kinase activity and SQ/TQ domain of Chk2 kinase as well as N-terminal domain of Wip1 phosphatase are required for regulation of Chk2 by Wip1. Intrinsic kinase activity and SQ/TQ domain of Chk2 kinase as well as N-terminal domain of Wip1 phosphatase are required for regulation of Chk2 by Wip1. Intrinsic kinase activity and SQ/TQ domain of Chk2 kinase as well as N-terminal domain of Wip1 phosphatase are required for regulation of Chk2 by Wip1. The Journal of biological chemistry, 281, 34, 24847-62 The Journal of biological chemistry, 281, 34, 24847-62 The Journal of biological chemistry, 281, 34, 24847-62 2006/08/25 English Disclose to all
Akinori Yoda, Xiao Zhou Xu, Nobuyuki Onishi, Kyoko Toyoshima, Hiroko Fujimoto, Naoko Kato, Isao Oishi, Takeshi Kondo, Yasuhiro Minami Akinori Yoda, Xiao Zhou Xu, Nobuyuki Onishi, Kyoko Toyoshima, Hiroko Fujimoto, Naoko Kato, Isao Oishi, Takeshi Kondo, Yasuhiro Minami Akinori Yoda, Xiao Zhou Xu, Nobuyuki Onishi, Kyoko Toyoshima, Hiroko Fujimoto, Naoko Kato, Isao Oishi, Takeshi Kondo, Yasuhiro Minami Intrinsic kinase activity and SQ/TQ domain of Chk2 kinase as well as N-terminal domain of Wip1 phosphatase are required for regulation of Chk2 by Wip1 Intrinsic kinase activity and SQ/TQ domain of Chk2 kinase as well as N-terminal domain of Wip1 phosphatase are required for regulation of Chk2 by Wip1 Intrinsic kinase activity and SQ/TQ domain of Chk2 kinase as well as N-terminal domain of Wip1 phosphatase are required for regulation of Chk2 by Wip1 JOURNAL OF BIOLOGICAL CHEMISTRY, 281, 34, 24847-24862 JOURNAL OF BIOLOGICAL CHEMISTRY, 281, 34, 24847-24862 JOURNAL OF BIOLOGICAL CHEMISTRY, 281, 34, 24847-24862 2006/08 English Disclose to all
H. Fujimoto, N. Onishi, N. Kato, M. Takekawa, X. Z. Xu, A. Kosugi, T. Kondo, M. Imamura, I. Oishi, A. Yoda, Y. Minami H. Fujimoto, N. Onishi, N. Kato, M. Takekawa, X. Z. Xu, A. Kosugi, T. Kondo, M. Imamura, I. Oishi, A. Yoda, Y. Minami H. Fujimoto, N. Onishi, N. Kato, M. Takekawa, X. Z. Xu, A. Kosugi, T. Kondo, M. Imamura, I. Oishi, A. Yoda, Y. Minami Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase CELL DEATH AND DIFFERENTIATION, 13, 7, 1170-1180 CELL DEATH AND DIFFERENTIATION, 13, 7, 1170-1180 CELL DEATH AND DIFFERENTIATION, 13, 7, 1170-1180 2006/07 English Disclose to all
H. Fujimoto, N. Onishi, N. Kato, M. Takekawa, X. Z. Xu, A. Kosugi, T. Kondo, M. Imamura, I. Oishi, A. Yoda, Y. Minami H. Fujimoto, N. Onishi, N. Kato, M. Takekawa, X. Z. Xu, A. Kosugi, T. Kondo, M. Imamura, I. Oishi, A. Yoda, Y. Minami H. Fujimoto, N. Onishi, N. Kato, M. Takekawa, X. Z. Xu, A. Kosugi, T. Kondo, M. Imamura, I. Oishi, A. Yoda, Y. Minami Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase CELL DEATH AND DIFFERENTIATION, 13, 7, 1170-1180 CELL DEATH AND DIFFERENTIATION, 13, 7, 1170-1180 CELL DEATH AND DIFFERENTIATION, 13, 7, 1170-1180 2006/07 English Disclose to all
Wip1ホスファターゼによるATMキナーゼを介したDNA損傷応答シグナルの抑制機構 Wip1ホスファターゼによるATMキナーゼを介したDNA損傷応答シグナルの抑制機構 2006 Disclose to all
Chk2キナーゼとWip1ホスファターゼの構造機能連関 Chk2キナーゼとWip1ホスファターゼの構造機能連関 2006 Disclose to all
Wip1 phosphatase is a negative regulator for ATM-mediated DNA damage response Wip1 phosphatase is a negative regulator for ATM-mediated DNA damage response 2006 Disclose to all
Structure-function analyses of Chk2 kinase and Wip1 phosphatase Structure-function analyses of Chk2 kinase and Wip1 phosphatase 2006 Disclose to all
Sa Kan Yoo, Nobuyuki Onishi, Naoko Kato, Akinori Yoda, Yasuhiro Minami Sa Kan Yoo, Nobuyuki Onishi, Naoko Kato, Akinori Yoda, Yasuhiro Minami Relationship between abnormalities of genes involved in DNA damage responses and malignant tumors/autoimmune diseases DNA損傷応答関連遺伝子の異常と悪性腫瘍・自己免疫疾患との関連について Relationship between abnormalities of genes involved in DNA damage responses and malignant tumors/autoimmune diseases Japanese Journal of Clinical Immunology, 29, 3, 136-147 日本臨床免疫学会会誌, 29, 3, 136-147 Japanese Journal of Clinical Immunology, 29, 3, 136-147 2006 English Disclose to all
Chk2キナーゼとWip1ホスファターゼの構造機能連関(Structure/function relationships in Chk2 kinase and Wip1 phosphatase)(英語) Chk2キナーゼとWip1ホスファターゼの構造機能連関(Structure/function relationships in Chk2 kinase and Wip1 phosphatase)(英語) 日本癌学会総会記事, 巻, 65回, pp. 164-164 日本癌学会総会記事, 巻, 65回, pp. 164-164 , 巻, 65回, pp. 164-164 2006 Disclose to all
Wip1ホスファターゼによるATMキナーゼを介したDNA損傷応答シグナルの抑制機構 Wip1ホスファターゼによるATMキナーゼを介したDNA損傷応答シグナルの抑制機構 日本癌学会65回総会記事, pp. 164-165 日本癌学会65回総会記事, pp. 164-165 , pp. 164-165 2006 Disclose to all
Chk2キナーゼとWip1ホスファターゼの構造機能連関(Structure/function relationships in Chk2 kinase and Wip1 phosphatase)(英語) Chk2キナーゼとWip1ホスファターゼの構造機能連関(Structure/function relationships in Chk2 kinase and Wip1 phosphatase)(英語) 日本癌学会65回総会記事, pp. 164-164 日本癌学会65回総会記事, pp. 164-164 , pp. 164-164 2006 Disclose to all
【分子メカニズムから解き明かす疾患のサイエンス】 癌 DNA損傷応答システムとその破綻による癌化 【分子メカニズムから解き明かす疾患のサイエンス】 癌 DNA損傷応答システムとその破綻による癌化 実験医学, 24巻, 10号, pp. 1408-1415 実験医学, 24巻, 10号, pp. 1408-1415 , 24巻, 10号, pp. 1408-1415 2006 Disclose to all
Genetically Engineered Mice Handbook / Mouse Models for Developmental Biology: Functional Analysis for Ror and Wnt Signaling Genetically Engineered Mice Handbook / Mouse Models for Developmental Biology: Functional Analysis for Ror and Wnt Signaling Taylor & Francis Taylor & Francis 2006 Disclose to all
Wip1 phosphatase is a negative regulator for ATM-mediated DNA damage response Wip1 phosphatase is a negative regulator for ATM-mediated DNA damage response Wip1 phosphatase is a negative regulator for ATM-mediated DNA damage response 2006 Disclose to all
Structure-function analyses of Chk2 kinase and Wip1 phosphatase Structure-function analyses of Chk2 kinase and Wip1 phosphatase Structure-function analyses of Chk2 kinase and Wip1 phosphatase 2006 Disclose to all
Genetically Engineered Mice Handbook / Mouse Models for Developmental Biology: Functional Analysis for Ror and Wnt Signaling Genetically Engineered Mice Handbook / Mouse Models for Developmental Biology: Functional Analysis for Ror and Wnt Signaling Genetically Engineered Mice Handbook / Mouse Models for Developmental Biology: Functional Analysis for Ror and Wnt Signaling Taylor & Francis Taylor & Francis Taylor & Francis 2006 Disclose to all
Akira Nomachi, Michiru Nishita, Shuichi Kani, Akira Kikuchi, Akinori Yoda, Yasuhiro Minami Akira Nomachi, Michiru Nishita, Shuichi Kani, Akira Kikuchi, Akinori Yoda, Yasuhiro Minami Akira Nomachi, Michiru Nishita, Shuichi Kani, Akira Kikuchi, Akinori Yoda, Yasuhiro Minami Ror2-mediated cytoskeletal reorganization by differential regulation of Dishevelled proteins Ror2-mediated cytoskeletal reorganization by differential regulation of Dishevelled proteins Ror2-mediated cytoskeletal reorganization by differential regulation of Dishevelled proteins CELL STRUCTURE AND FUNCTION, 30, 107-107 CELL STRUCTURE AND FUNCTION, 30, 107-107 CELL STRUCTURE AND FUNCTION, 30, 107-107 2005/06 English Research paper, summary (international conference) Disclose to all
Akira Nomachi, Michiru Nishita, Shuichi Kani, Akira Kikuchi, Akinori Yoda, Yasuhiro Minami Akira Nomachi, Michiru Nishita, Shuichi Kani, Akira Kikuchi, Akinori Yoda, Yasuhiro Minami Akira Nomachi, Michiru Nishita, Shuichi Kani, Akira Kikuchi, Akinori Yoda, Yasuhiro Minami Ror2-mediated cytoskeletal reorganization by differential regulation of Dishevelled proteins Ror2-mediated cytoskeletal reorganization by differential regulation of Dishevelled proteins Ror2-mediated cytoskeletal reorganization by differential regulation of Dishevelled proteins CELL STRUCTURE AND FUNCTION, 30, 107-107 CELL STRUCTURE AND FUNCTION, 30, 107-107 CELL STRUCTURE AND FUNCTION, 30, 107-107 2005/06 English Research paper, summary (international conference) Disclose to all
Akinori Yoda, Hiroko Kouike, Hideyuki Okano, Hitoshi Sawa Akinori Yoda, Hiroko Kouike, Hideyuki Okano, Hitoshi Sawa Akinori Yoda, Hiroko Kouike, Hideyuki Okano, Hitoshi Sawa Components of the transcriptional Mediator complex are required for asymmetric cell division in C. elegans. Components of the transcriptional Mediator complex are required for asymmetric cell division in C. elegans. Components of the transcriptional Mediator complex are required for asymmetric cell division in C. elegans. Development (Cambridge, England), 132, 8, 1885-93 Development (Cambridge, England), 132, 8, 1885-93 Development (Cambridge, England), 132, 8, 1885-93 2005/04 English Disclose to all
A Yoda, H Kouike, H Okano, H Sawa A Yoda, H Kouike, H Okano, H Sawa A Yoda, H Kouike, H Okano, H Sawa Components of the transcriptional Mediator complex are required for asymmetric cell division in C-elegans Components of the transcriptional Mediator complex are required for asymmetric cell division in C-elegans Components of the transcriptional Mediator complex are required for asymmetric cell division in C-elegans DEVELOPMENT, 132, 8, 1885-1893 DEVELOPMENT, 132, 8, 1885-1893 DEVELOPMENT, 132, 8, 1885-1893 2005/04 English Disclose to all
DNA損傷に伴う細胞周期チェックポイントの作動・解除及びアポトーシスの制御機構とがんの分子標的治療への応用 DNA損傷に伴う細胞周期チェックポイントの作動・解除及びアポトーシスの制御機構とがんの分子標的治療への応用 2005 Disclose to all
受容体型チロシンキナーゼRor2の細胞外・細胞内ドメイン依存的機能によるWntシグナルおよび細胞骨格系の制御 受容体型チロシンキナーゼRor2の細胞外・細胞内ドメイン依存的機能によるWntシグナルおよび細胞骨格系の制御 2005 Disclose to all
DNA損傷応答における核内Chk2キナーゼ・Wip1ホスファターゼの構造・機能連関解析 DNA損傷応答における核内Chk2キナーゼ・Wip1ホスファターゼの構造・機能連関解析 2005 Disclose to all
Wip1 phosphatase interacts with SQ/TQ domain of Chk2 kinase and dephosphorylates threonine68 through N-terminal region of Wip1 Wip1 phosphatase interacts with SQ/TQ domain of Chk2 kinase and dephosphorylates threonine68 through N-terminal region of Wip1 2005 Disclose to all
Structure-function analyses of Chk2 kinase and Wip1 phosphatase Structure-function analyses of Chk2 kinase and Wip1 phosphatase 2005 Disclose to all
DNA損傷とアポトーシス研究のがん治療への応用 DNA損傷に伴う細胞周期チェックポイントの作動・解除及びアポトーシスの制御機構とがんの分子標的治療への応用 DNA損傷とアポトーシス研究のがん治療への応用 DNA損傷に伴う細胞周期チェックポイントの作動・解除及びアポトーシスの制御機構とがんの分子標的治療への応用 日本癌学会64回総会記事, pp.29-30 日本癌学会64回総会記事, pp.29-30 , pp.29-30 2005 Disclose to all
細胞周期チェックポイントのオン・オフ機構 細胞周期チェックポイントのオン・オフ機構 放射線生物研究, 40巻, 2号, pp.67-81 放射線生物研究, 40巻, 2号, pp.67-81 , 40巻, 2号, pp.67-81 2005 Disclose to all
Wip1 phosphatase interacts with SQ/TQ domain of Chk2 kinase and dephosphorylates threonine68 through N-terminal region of Wip1 Wip1 phosphatase interacts with SQ/TQ domain of Chk2 kinase and dephosphorylates threonine68 through N-terminal region of Wip1 Wip1 phosphatase interacts with SQ/TQ domain of Chk2 kinase and dephosphorylates threonine68 through N-terminal region of Wip1 2005 Disclose to all
Structure-function analyses of Chk2 kinase and Wip1 phosphatase Structure-function analyses of Chk2 kinase and Wip1 phosphatase Structure-function analyses of Chk2 kinase and Wip1 phosphatase 2005 Disclose to all
N Kato, H Fujimoto, A Yoda, Oishi, I, N Matsumura, T Kondo, J Tsukada, Y Tanaka, M Imamura, Y Minami N Kato, H Fujimoto, A Yoda, Oishi, I, N Matsumura, T Kondo, J Tsukada, Y Tanaka, M Imamura, Y Minami N Kato, H Fujimoto, A Yoda, Oishi, I, N Matsumura, T Kondo, J Tsukada, Y Tanaka, M Imamura, Y Minami Regulation of Chk2 gene expression in lymphoid malignancies: involvement of epigenetic mechanisms in Hodgkin's lymphoma cell lines Regulation of Chk2 gene expression in lymphoid malignancies: involvement of epigenetic mechanisms in Hodgkin's lymphoma cell lines Regulation of Chk2 gene expression in lymphoid malignancies: involvement of epigenetic mechanisms in Hodgkin's lymphoma cell lines CELL DEATH AND DIFFERENTIATION, 11, S153-S161 CELL DEATH AND DIFFERENTIATION, 11, S153-S161 CELL DEATH AND DIFFERENTIATION, 11, S153-S161 2004/12 English Disclose to all
N Kato, H Fujimoto, A Yoda, Oishi, I, N Matsumura, T Kondo, J Tsukada, Y Tanaka, M Imamura, Y Minami N Kato, H Fujimoto, A Yoda, Oishi, I, N Matsumura, T Kondo, J Tsukada, Y Tanaka, M Imamura, Y Minami N Kato, H Fujimoto, A Yoda, Oishi, I, N Matsumura, T Kondo, J Tsukada, Y Tanaka, M Imamura, Y Minami Regulation of Chk2 gene expression in lymphoid malignancies: involvement of epigenetic mechanisms in Hodgkin's lymphoma cell lines Regulation of Chk2 gene expression in lymphoid malignancies: involvement of epigenetic mechanisms in Hodgkin's lymphoma cell lines Regulation of Chk2 gene expression in lymphoid malignancies: involvement of epigenetic mechanisms in Hodgkin's lymphoma cell lines CELL DEATH AND DIFFERENTIATION, 11, S153-S161 CELL DEATH AND DIFFERENTIATION, 11, S153-S161 CELL DEATH AND DIFFERENTIATION, 11, S153-S161 2004/12 English Disclose to all
Shuichi Kani, Isao Oishi, Hiroyuki Yamamoto, Akinori Yoda, Hiroaki Suzuki, Akira Nomachi, Kengo Iozumi, Michiru Nishita, Akira Kikuchi, Toru Takumi, Yasuhiro Minami Shuichi Kani, Isao Oishi, Hiroyuki Yamamoto, Akinori Yoda, Hiroaki Suzuki, Akira Nomachi, Kengo Iozumi, Michiru Nishita, Akira Kikuchi, Toru Takumi, Yasuhiro Minami The receptor tyrosine kinase Ror2 associates with and is activated by casein kinase Iepsilon. The receptor tyrosine kinase Ror2 associates with and is activated by casein kinase Ⅰε The receptor tyrosine kinase Ror2 associates with and is activated by casein kinase Iepsilon. The Journal of biological chemistry, 279, 48, 50102-9 , 279, 48, 50102-9 The Journal of biological chemistry, 279, 48, 50102-9 2004/11/26 English Disclose to all
Shuichi Kani, Isao Oishi, Hiroyuki Yamamoto, Akinori Yoda, Hiroaki Suzuki, Akira Nomachi, Kengo Iozumi, Michiru Nishita, Akira Kikuchi, Toru Takumi, Yasuhiro Minami Shuichi Kani, Isao Oishi, Hiroyuki Yamamoto, Akinori Yoda, Hiroaki Suzuki, Akira Nomachi, Kengo Iozumi, Michiru Nishita, Akira Kikuchi, Toru Takumi, Yasuhiro Minami Shuichi Kani, Isao Oishi, Hiroyuki Yamamoto, Akinori Yoda, Hiroaki Suzuki, Akira Nomachi, Kengo Iozumi, Michiru Nishita, Akira Kikuchi, Toru Takumi, Yasuhiro Minami The receptor tyrosine kinase Ror2 associates with and is activated by casein kinase Iepsilon. The receptor tyrosine kinase Ror2 associates with and is activated by casein kinase Iepsilon. The receptor tyrosine kinase Ror2 associates with and is activated by casein kinase Iepsilon. The Journal of biological chemistry, 279, 48, 50102-9 The Journal of biological chemistry, 279, 48, 50102-9 The Journal of biological chemistry, 279, 48, 50102-9 2004/11/26 English Disclose to all
Shuichi Kani, Isao Oishi, Hiroyuki Yamamoto, Akinori Yoda, Hiroaki Suzuki, Akira Nomachi, Kengo Iozumi, Michiru Nishita, Akira Kikuchi, Toru Takumi, Yasuhiro Minami Shuichi Kani, Isao Oishi, Hiroyuki Yamamoto, Akinori Yoda, Hiroaki Suzuki, Akira Nomachi, Kengo Iozumi, Michiru Nishita, Akira Kikuchi, Toru Takumi, Yasuhiro Minami Shuichi Kani, Isao Oishi, Hiroyuki Yamamoto, Akinori Yoda, Hiroaki Suzuki, Akira Nomachi, Kengo Iozumi, Michiru Nishita, Akira Kikuchi, Toru Takumi, Yasuhiro Minami The receptor tyrosine kinase Ror2 associates with and is activated by casein kinase Iepsilon. The receptor tyrosine kinase Ror2 associates with and is activated by casein kinase Iepsilon. The receptor tyrosine kinase Ror2 associates with and is activated by casein kinase Iepsilon. The Journal of biological chemistry, 279, 48, 50102-9 The Journal of biological chemistry, 279, 48, 50102-9 The Journal of biological chemistry, 279, 48, 50102-9 2004/11/26 English Disclose to all
Shuichi Kani, Isao Oishi, Hiroyuki Yamamoto, Akinori Yoda, Hiroaki Suzuki, Akira Nomachi, Kengo Iozumi, Michiru Nishita, Akira Kikuchi, Toru Takumi, Yasuhiro Minami Shuichi Kani, Isao Oishi, Hiroyuki Yamamoto, Akinori Yoda, Hiroaki Suzuki, Akira Nomachi, Kengo Iozumi, Michiru Nishita, Akira Kikuchi, Toru Takumi, Yasuhiro Minami Shuichi Kani, Isao Oishi, Hiroyuki Yamamoto, Akinori Yoda, Hiroaki Suzuki, Akira Nomachi, Kengo Iozumi, Michiru Nishita, Akira Kikuchi, Toru Takumi, Yasuhiro Minami The receptor tyrosine kinase Ror2 associates with and is activated by casein kinase Iepsilon. The receptor tyrosine kinase Ror2 associates with and is activated by casein kinase Iepsilon. The receptor tyrosine kinase Ror2 associates with and is activated by casein kinase Iepsilon. The Journal of biological chemistry, 279, 48, 50102-9 The Journal of biological chemistry, 279, 48, 50102-9 The Journal of biological chemistry, 279, 48, 50102-9 2004/11/26 English Disclose to all
Shuichi Kani, Isao Oishi, Hiroyuki Yamamoto, Akinori Yoda, Hiroaki Suzuki, Akira Nomachi, Kengo Iozumi, Michiru Nishita, Akira Kikuchi, Toru Takumi, Yasuhiro Minami Shuichi Kani, Isao Oishi, Hiroyuki Yamamoto, Akinori Yoda, Hiroaki Suzuki, Akira Nomachi, Kengo Iozumi, Michiru Nishita, Akira Kikuchi, Toru Takumi, Yasuhiro Minami Shuichi Kani, Isao Oishi, Hiroyuki Yamamoto, Akinori Yoda, Hiroaki Suzuki, Akira Nomachi, Kengo Iozumi, Michiru Nishita, Akira Kikuchi, Toru Takumi, Yasuhiro Minami The receptor tyrosine kinase Ror2 associates with and is activated by casein kinase Iepsilon. The receptor tyrosine kinase Ror2 associates with and is activated by casein kinase Iepsilon. The receptor tyrosine kinase Ror2 associates with and is activated by casein kinase Iepsilon. The Journal of biological chemistry, 279, 48, 50102-9 The Journal of biological chemistry, 279, 48, 50102-9 The Journal of biological chemistry, 279, 48, 50102-9 2004/11/26 English Disclose to all
M Wirschell, G Pazour, A Yoda, M Hirono, R Kamiya, GB Witman M Wirschell, G Pazour, A Yoda, M Hirono, R Kamiya, GB Witman M Wirschell, G Pazour, A Yoda, M Hirono, R Kamiya, GB Witman Oda5p, a novel axonemal protein required for assembly of the outer dynein arm and an associated adenylate kinase Oda5p, a novel axonemal protein required for assembly of the outer dynein arm and an associated adenylate kinase Oda5p, a novel axonemal protein required for assembly of the outer dynein arm and an associated adenylate kinase MOLECULAR BIOLOGY OF THE CELL, 15, 6, 2729-2741 MOLECULAR BIOLOGY OF THE CELL, 15, 6, 2729-2741 MOLECULAR BIOLOGY OF THE CELL, 15, 6, 2729-2741 2004/06 English Disclose to all
M Wirschell, G Pazour, A Yoda, M Hirono, R Kamiya, GB Witman M Wirschell, G Pazour, A Yoda, M Hirono, R Kamiya, GB Witman M Wirschell, G Pazour, A Yoda, M Hirono, R Kamiya, GB Witman Oda5p, a novel axonemal protein required for assembly of the outer dynein arm and an associated adenylate kinase Oda5p, a novel axonemal protein required for assembly of the outer dynein arm and an associated adenylate kinase Oda5p, a novel axonemal protein required for assembly of the outer dynein arm and an associated adenylate kinase MOLECULAR BIOLOGY OF THE CELL, 15, 6, 2729-2741 MOLECULAR BIOLOGY OF THE CELL, 15, 6, 2729-2741 MOLECULAR BIOLOGY OF THE CELL, 15, 6, 2729-2741 2004/06 English Disclose to all
Shuichi Kani, Isao Oishi, Hiroyuki Yamamoto, Akinori Yoda, Hiroaki Suzuki, Akira Nomachi, Akira Kikuchi, Toru Takumi, Yasuhiro Minami Shuichi Kani, Isao Oishi, Hiroyuki Yamamoto, Akinori Yoda, Hiroaki Suzuki, Akira Nomachi, Akira Kikuchi, Toru Takumi, Yasuhiro Minami Shuichi Kani, Isao Oishi, Hiroyuki Yamamoto, Akinori Yoda, Hiroaki Suzuki, Akira Nomachi, Akira Kikuchi, Toru Takumi, Yasuhiro Minami The receptor tyrosine kinase Ror2 associates with and is activated by casein kinase I epsilon The receptor tyrosine kinase Ror2 associates with and is activated by casein kinase I epsilon The receptor tyrosine kinase Ror2 associates with and is activated by casein kinase I epsilon CELL STRUCTURE AND FUNCTION, 29, 76-76 CELL STRUCTURE AND FUNCTION, 29, 76-76 CELL STRUCTURE AND FUNCTION, 29, 76-76 2004/05 English Research paper, summary (international conference) Disclose to all
Nobuyuki Onishi, Hiroko Fujimoto, Naoko Kato, Xiao Zhou Xu, Marika Horiuchi, Mutsuhiro Takekawa, Akinori Yoda, Isao Oishi, Yasuhiro Minami Nobuyuki Onishi, Hiroko Fujimoto, Naoko Kato, Xiao Zhou Xu, Marika Horiuchi, Mutsuhiro Takekawa, Akinori Yoda, Isao Oishi, Yasuhiro Minami Nobuyuki Onishi, Hiroko Fujimoto, Naoko Kato, Xiao Zhou Xu, Marika Horiuchi, Mutsuhiro Takekawa, Akinori Yoda, Isao Oishi, Yasuhiro Minami Structure-function analyses of protein kinase and phosphatase involved in intranuclear signaling in response to DNA damage Structure-function analyses of protein kinase and phosphatase involved in intranuclear signaling in response to DNA damage Structure-function analyses of protein kinase and phosphatase involved in intranuclear signaling in response to DNA damage CELL STRUCTURE AND FUNCTION, 29, 80-80 CELL STRUCTURE AND FUNCTION, 29, 80-80 CELL STRUCTURE AND FUNCTION, 29, 80-80 2004/05 English Research paper, summary (international conference) Disclose to all
Nobuyuki Onishi, Hiroko Fujimoto, Naoko Kato, Xiao Zhou Xu, Marika Horiuchi, Mutsuhiro Takekawa, Akinori Yoda, Isao Oishi, Yasuhiro Minami Nobuyuki Onishi, Hiroko Fujimoto, Naoko Kato, Xiao Zhou Xu, Marika Horiuchi, Mutsuhiro Takekawa, Akinori Yoda, Isao Oishi, Yasuhiro Minami Nobuyuki Onishi, Hiroko Fujimoto, Naoko Kato, Xiao Zhou Xu, Marika Horiuchi, Mutsuhiro Takekawa, Akinori Yoda, Isao Oishi, Yasuhiro Minami Structure-function analyses of protein kinase and phosphatase involved in intranuclear signaling in response to DNA damage Structure-function analyses of protein kinase and phosphatase involved in intranuclear signaling in response to DNA damage Structure-function analyses of protein kinase and phosphatase involved in intranuclear signaling in response to DNA damage CELL STRUCTURE AND FUNCTION, 29, 80-80 CELL STRUCTURE AND FUNCTION, 29, 80-80 CELL STRUCTURE AND FUNCTION, 29, 80-80 2004/05 English Research paper, summary (international conference) Disclose to all
DNA損傷応答におけるWip1を介した細胞周期チェックポイントの解除機構 DNA損傷応答におけるWip1を介した細胞周期チェックポイントの解除機構 2004 Disclose to all
形態形成のシグナル伝達における受容体型チロシンキナーゼRor2とFGFR3の機能連関解析 形態形成のシグナル伝達における受容体型チロシンキナーゼRor2とFGFR3の機能連関解析 2004 Disclose to all
放射線によるDNA損傷に伴う細胞周期チェックポイントのオン・オフ機構 放射線によるDNA損傷に伴う細胞周期チェックポイントのオン・オフ機構 2004 Disclose to all
WntとRor2によるPCP経路の制御 WntとRor2によるPCP経路の制御 細胞工学, 23巻, 6, pp. 642-646 細胞工学, 23巻, 6, pp. 642-646 , 23巻, 6, pp. 642-646 2004 Disclose to all
放射線によるDNA損傷に伴う細胞周期チェックポイントのオン・オフ機構 放射線によるDNA損傷に伴う細胞周期チェックポイントのオン・オフ機構 日本放射線影響学会大会講演要旨集, 巻, 47回, pp. 54-54 日本放射線影響学会大会講演要旨集, 巻, 47回, pp. 54-54 , 巻, 47回, pp. 54-54 2004 Disclose to all
DNA損傷応答におけるチェックポイントとDNA修復のクロストーク機構の解析 DNA損傷応答におけるチェックポイントとDNA修復のクロストーク機構の解析 放射線生物研究, 39巻, 3号, pp. 244-257 放射線生物研究, 39巻, 3号, pp. 244-257 , 39巻, 3号, pp. 244-257 2004 Disclose to all
DNA損傷応答におけるWip1による細胞周期チェックポイントの解除機構 DNA損傷応答におけるWip1による細胞周期チェックポイントの解除機構 Cancer Science, 95巻, Suppl., pp. 440-440 Cancer Science, 95巻, Suppl., pp. 440-440 , 95巻, Suppl., pp. 440-440 2004 Disclose to all
Akinori Yoda, Isao Oishi, Yasuhiro Minami Akinori Yoda, Isao Oishi, Yasuhiro Minami Akinori Yoda, Isao Oishi, Yasuhiro Minami Expression and function of the Ror-family receptor tyrosine kinases during development: lessons from genetic analyses of nematodes, mice, and humans. Expression and function of the Ror-family receptor tyrosine kinases during development: lessons from genetic analyses of nematodes, mice, and humans. Expression and function of the Ror-family receptor tyrosine kinases during development: lessons from genetic analyses of nematodes, mice, and humans. Journal of receptor and signal transduction research, 23, 1, 1-15 Journal of receptor and signal transduction research, 23, 1, 1-15 Journal of receptor and signal transduction research, 23, 1, 1-15 2003/02 English Disclose to all
DNA損傷応答における核内シグナル伝達に関わる蛋白質キナーゼ・ホスファターゼの構造・機能連関解析 DNA損傷応答における核内シグナル伝達に関わる蛋白質キナーゼ・ホスファターゼの構造・機能連関解析 2003 Disclose to all
CKIεによる受容体型チロシンキナーゼRor2の活性化機構 CKIεによる受容体型チロシンキナーゼRor2の活性化機構 2003 Disclose to all
CKIeによる受容体型チロシンキナーゼRor2の活性化機構 CKIeによる受容体型チロシンキナーゼRor2の活性化機構 2003 Disclose to all
A Yoda, Oishi, I, Y Minami A Yoda, Oishi, I, Y Minami A Yoda, Oishi, I, Y Minami Expression and function of the Ror-family receptor tyrosine kinases during development: Lessons from genetic analyses of nematodes, mice, and humans Expression and function of the Ror-family receptor tyrosine kinases during development: Lessons from genetic analyses of nematodes, mice, and humans Expression and function of the Ror-family receptor tyrosine kinases during development: Lessons from genetic analyses of nematodes, mice, and humans JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 23, 1, 1-15 JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 23, 1, 1-15 JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 23, 1, 1-15 2003 English Book review, literature introduction, etc. Disclose to all
M Wirschell, G Pazour, A Yoda, M Hirono, R Kamiya, GB Witman M Wirschell, G Pazour, A Yoda, M Hirono, R Kamiya, GB Witman M Wirschell, G Pazour, A Yoda, M Hirono, R Kamiya, GB Witman Oda5 is part of a novel axonemal complex required for outer dynein arm assembly in Chlamydomonas Oda5 is part of a novel axonemal complex required for outer dynein arm assembly in Chlamydomonas Oda5 is part of a novel axonemal complex required for outer dynein arm assembly in Chlamydomonas MOLECULAR BIOLOGY OF THE CELL, 13, 327A-327A MOLECULAR BIOLOGY OF THE CELL, 13, 327A-327A MOLECULAR BIOLOGY OF THE CELL, 13, 327A-327A 2002/11 English Research paper, summary (international conference) Disclose to all
MB Wirschell, A Yoda, M Hirono, R Kamiya, GJ Pazour, GB Witman MB Wirschell, A Yoda, M Hirono, R Kamiya, GJ Pazour, GB Witman MB Wirschell, A Yoda, M Hirono, R Kamiya, GJ Pazour, GB Witman ODA5, a novel gene required for outer dynein arm assembly in Chlamydomonas reinhardtii ODA5, a novel gene required for outer dynein arm assembly in Chlamydomonas reinhardtii ODA5, a novel gene required for outer dynein arm assembly in Chlamydomonas reinhardtii MOLECULAR BIOLOGY OF THE CELL, 12, 443A-443A MOLECULAR BIOLOGY OF THE CELL, 12, 443A-443A MOLECULAR BIOLOGY OF THE CELL, 12, 443A-443A 2001/11 English Research paper, summary (international conference) Disclose to all
Masafumi Hirono, Akinori Yoda Masafumi Hirono, Akinori Yoda Masafumi Hirono, Akinori Yoda Isolation and phenotypic characterization of Chlamydomonas mutants defective in cytokinesis. Isolation and phenotypic characterization of Chlamydomonas mutants defective in cytokinesis. Isolation and phenotypic characterization of Chlamydomonas mutants defective in cytokinesis. Cell structure and Function, 22, 1, 1-5 Cell structure and Function, 22, 1, 1-5 Cell structure and Function, 22, 1, 1-5 1997 Disclose to all

  • <<
  • >>
Title language:
External funds: competitive funds and Grants-in-Aid for Scientific Research (Kakenhi)
Type Position Title(Japanese) Title(English) Period
基盤研究(B) Representative 難治性白血病モデルを用いた新規標的の診断治療開発 (2019年度分) 2019/04/01-2020/03/31
新学術領域研究(研究領域提案型) Representative スプライシング因子変異細胞のネオ・セルフとがん免疫療法 (2019年度分) 2019/04/01-2020/03/31
新学術領域研究(研究領域提案型) Representative スプライシング因子変異細胞のネオ・セルフとがん免疫療法 (2020年度分) 2020/04/01-2021/03/31
基盤研究(B) Representative 難治性白血病モデルを用いた新規標的の診断治療開発 (2020年度分) 2020/04/01-2021/03/31